Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-1|1|434|n/a|n/a|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-2|1|469|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-3|1|483|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-4|1|483|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-5|1|483|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-6|1|525|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-7|1|546|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-8|1|560|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-9|1|581|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-10|1|595|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-11|1|609|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-12|1|616|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-13|1|623|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-14|1|623|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-15|1|623|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-16|1|623|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-17|1|630|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-18|1|630|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-19|1|630|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-20|1|637|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-21|1|644|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-22|1|672|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-23|1|672|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors 
|11-1-1-24|1|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-25|1|672|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-26|1|686|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-27|1|686|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-28|1|693|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-29|1|693|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-30|1|693|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-31|1|693|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-32|1|707|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-33|1|721|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-34|1|735|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-35|1|735|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-36|1|735|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-37|1|735|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-38|1|742|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-39|1|742|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-40|1|742|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-41|1|742|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-42|1|749|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-43|1|749|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-44|1|749|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-45|1|749|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-46|1|749|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-47|1|749|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-48|1|749|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-49|1|756|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-50|1|763|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-51|1|763|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-52|1|763|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-53|1|763|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-54|1|770|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-55|1|777|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-56|1|812|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-57|1|840|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-58|1|840|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-59|1|847|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-60|1|861|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-61|1|861|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-62|1|868|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-63|1|896|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-64|1|903|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-65|1|903|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-66|1|910|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-67|1|910|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-68|1|917|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-69|1|924|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-70|1|938|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-71|1|945|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-72|1|966|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-73|1|980|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-74|1|1001|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-75|1|1001|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-76|1|1001|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-77|1|1036|Other deterministic changes|Mammary gland|n/a|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-78|1|1050|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-79|1|1085|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-1|Wa-Gy 0,AW00_00.0A5NIH AW00_007.0A0NIH|1| 49|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|80 (80 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-1-80|1|1092|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-1|2|546|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-2|2|546|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-3|2|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-4|2|546|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-5|2|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-6|2|532|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-7|2|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-8|2|749|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-9|2|560|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-10|2|616|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-11|2|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-12|2|532|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-13|2|525|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-14|2|539|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-15|2|651|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-16|2|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-17|2|455|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-18|2|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-19|2|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-20|2|658|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-21|2|399|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-22|2|462|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-23|2|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-24|2|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-25|2|448|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-26|2|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-27|2|616|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-28|2|518|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-29|2|574|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-30|2|567|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-31|2|406|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-32|2|476|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-33|2|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-34|2|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-35|2|553|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-36|2|707|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-37|2|497|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-38|2|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-39|2|581|Other deterministic changes|Mammary gland|n/a|
11-1-2|WaOe-Gy 0,AW00_007.0B0NIH|1| 49|estrogen|4|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-2-40|2|546|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-1|3|511|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-2|3|602|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-3|3|812|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-4|3|826|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-5|3|847|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-6|3|875|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-7|3|903|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-8|3|910|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-9|3|910|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-10|3|945|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-11|3|952|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-12|3|966|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-13|3|973|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-14|3|987|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-15|3|1001|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-16|3|1001|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-17|3|1008|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-18|3|1008|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-19|3|1008|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-20|3|1008|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-21|3|1015|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-22|3|1022|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-23|3|1029|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-24|3|1036|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-25|3|1036|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-26|3|1036|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-27|3|1050|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-28|3|1057|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-29|3|1057|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-30|3|1099|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-31|3|1106|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-32|3|1113|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-33|3|1113|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-34|3|1127|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-35|3|1127|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-36|3|1211|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-37|3|1211|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-38|3|1232|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-39|3|1267|Other deterministic changes|Mammary gland|n/a|
11-1-3|WaOv-Gy 0,AW00_007.0C0NIH|1| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-3-40|3|1316|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-1|4|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-2|4|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-3|4|350|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-4|4|518|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-5|4|532|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-6|4|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-7|4|539|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-8|4|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-9|4|553|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-10|4|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-11|4|252|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-12|4|518|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-13|4|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-14|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-15|4|441|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-16|4|413|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-17|4|658|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-18|4|658|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-19|4|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-20|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-21|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-22|4|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-23|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-24|4|707|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-25|4|511|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-26|4|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-27|4|693|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-28|4|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-29|4|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-30|4|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-31|4|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-32|4|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-33|4|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-34|4|609|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-35|4|728|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-36|4|462|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-37|4|364|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-38|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-39|4|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|1| 49|estrogen|2|milligrams|not applicable or not supplied| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-40|4|203|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-1|4|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-2|4|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-3|4|350|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-4|4|518|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-5|4|532|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-6|4|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-7|4|539|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-8|4|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-9|4|553|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-10|4|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-11|4|252|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-12|4|518|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-13|4|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-14|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-15|4|441|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-16|4|413|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-17|4|658|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-18|4|658|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-19|4|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-20|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-21|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-22|4|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-23|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-24|4|707|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-25|4|511|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-26|4|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-27|4|693|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-28|4|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-29|4|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-30|4|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-31|4|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-32|4|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-33|4|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-34|4|609|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-35|4|728|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-36|4|462|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-37|4|364|Other deterministic changes|Mammary gland|n/a|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-38|4|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-39|4|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-4|WaOeOv-Gy 0,AW00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-4-40|4|203|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-1|5|469|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-2|5|497|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-3|5|532|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-4|5|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-5|5|581|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-6|5|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-7|5|623|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-8|5|644|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-9|5|651|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-10|5|686|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-11|5|707|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-12|5|707|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-13|5|714|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-14|5|714|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-15|5|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-16|5|770|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-17|5|770|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-18|5|777|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-19|5|777|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-20|5|784|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-21|5|784|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-22|5|805|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-23|5|805|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-24|5|819|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-25|5|819|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-26|5|819|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-27|5|826|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-28|5|847|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-29|5|882|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-30|5|889|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-31|5|903|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-32|5|910|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-33|5|924|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-34|5|931|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-35|5|938|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-36|5|938|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 266 - fibroadenoma|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-37|5|945|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-38|5|966|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-39|5|1008|Other deterministic changes|Mammary gland|n/a|
11-1-5|XWa-Gy 0.25,AWXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-5-40|5|1029|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-1|6|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-2|6|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-3|6|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-4|6|574|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-5|6|343|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-6|6|574|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-7|6|504|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-8|6|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-9|6|259|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-10|6|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-11|6|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-12|6|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-13|6|553|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-14|6|504|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-15|6|511|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-16|6|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-17|6|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-18|6|413|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-19|6|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-20|6|245|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-21|6|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-22|6|651|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-23|6|385|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-24|6|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-25|6|511|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-26|6|665|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-27|6|581|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-28|6|434|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-29|6|581|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-30|6|651|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-31|6|581|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-32|6|595|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-33|6|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-34|6|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-35|6|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-36|6|483|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-37|6|784|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-38|6|497|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-39|6|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-40|6|504|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-1|6|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-2|6|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-3|6|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-4|6|574|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-5|6|343|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-6|6|574|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-7|6|504|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-8|6|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-9|6|259|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-10|6|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-11|6|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-12|6|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-13|6|553|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-14|6|504|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-15|6|511|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-16|6|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-17|6|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-18|6|413|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-19|6|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-20|6|245|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-21|6|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-22|6|651|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-23|6|385|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-24|6|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-25|6|511|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-26|6|665|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-27|6|581|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-28|6|434|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-29|6|581|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-30|6|651|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-31|6|581|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-32|6|595|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-33|6|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-34|6|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-35|6|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-36|6|483|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-37|6|784|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-38|6|497|Other deterministic changes|Mammary gland|n/a|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-39|6|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-6|XWaOe-Gy 0.25,AWXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-6-40|6|504|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-1|7|259|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-2|7|504|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-3|7|658|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-4|7|693|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-5|7|770|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-6|7|770|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-7|7|812|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-8|7|826|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-9|7|840|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-10|7|847|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-11|7|847|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-12|7|854|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-13|7|854|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-14|7|861|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-15|7|868|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-16|7|868|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-17|7|868|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-18|7|875|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-19|7|882|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-20|7|882|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-21|7|882|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-22|7|917|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-23|7|924|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-24|7|938|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-25|7|945|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-26|7|952|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-27|7|952|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-28|7|966|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-29|7|980|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-30|7|987|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-31|7|994|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-32|7|1001|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-33|7|1036|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-34|7|1036|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-35|7|1057|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-36|7|1071|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-37|7|1085|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-38|7|1092|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-39|7|1099|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-40|7|1120|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-1|7|259|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-2|7|504|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-3|7|658|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-4|7|693|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-5|7|770|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-6|7|770|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-7|7|812|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-8|7|826|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-9|7|840|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-10|7|847|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-11|7|847|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-12|7|854|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-13|7|854|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-14|7|861|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-15|7|868|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-16|7|868|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-17|7|868|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-18|7|875|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-19|7|882|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-20|7|882|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-21|7|882|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-22|7|917|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-23|7|924|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-24|7|938|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-25|7|945|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-26|7|952|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-27|7|952|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-28|7|966|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-29|7|980|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-30|7|987|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-31|7|994|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-32|7|1001|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-33|7|1036|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-34|7|1036|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-35|7|1057|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-36|7|1071|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-37|7|1085|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-38|7|1092|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-39|7|1099|Other deterministic changes|Mammary gland|n/a|
11-1-7|XWaOv-Gy 0.25,AWXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-7-40|7|1120|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-1|8|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-2|8|420|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-3|8|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-4|8|546|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-5|8|294|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-6|8|532|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-7|8|490|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-8|8|497|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-9|8|602|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-10|8|518|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-11|8|616|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-12|8|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-13|8|301|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-14|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-15|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-16|8|483|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-17|8|588|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-18|8|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-19|8|462|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-20|8|469|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-21|8|518|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-22|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-23|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-24|8|455|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-25|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-26|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-27|8|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-28|8|630|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-29|8|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-30|8|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-31|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  5,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-32|8|532|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-33|8|525|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-34|8|546|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-35|8|315|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-36|8|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-37|8|658|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-38|8|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-39|8|658|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-40|8|448|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-1|8|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-2|8|420|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-3|8|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-4|8|546|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-5|8|294|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-6|8|532|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-7|8|490|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-8|8|497|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-9|8|602|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-10|8|518|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-11|8|616|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-12|8|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-13|8|301|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-14|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-15|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-16|8|483|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-17|8|588|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-18|8|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-19|8|462|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-20|8|469|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-21|8|518|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-22|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-23|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-24|8|455|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-25|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-26|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-27|8|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-28|8|630|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-29|8|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-30|8|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-31|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  5,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-32|8|532|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-33|8|525|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-34|8|546|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-35|8|315|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-36|8|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-37|8|658|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-38|8|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-39|8|658|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-40|8|448|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-1|8|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-2|8|420|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-3|8|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-4|8|546|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-5|8|294|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-6|8|532|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-7|8|490|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-8|8|497|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-9|8|602|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-10|8|518|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-11|8|616|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-12|8|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-13|8|301|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-14|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-15|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-16|8|483|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-17|8|588|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-18|8|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-19|8|462|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-20|8|469|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-21|8|518|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-22|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-23|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-24|8|455|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-25|8|651|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-26|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-27|8|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-28|8|630|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-29|8|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-30|8|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-31|8|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  5,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-32|8|532|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-33|8|525|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-34|8|546|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-35|8|315|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-36|8|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-37|8|658|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-38|8|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-39|8|658|Other deterministic changes|Mammary gland|n/a|
11-1-8|XWaOeOv-Gy 0.25,AWXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-8-40|8|448|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-1|9|336|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-2|9|364|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-3|9|371|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-4|9|455|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-5|9|469|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-6|9|525|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-7|9|539|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-8|9|553|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-9|9|567|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-10|9|567|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-11|9|567|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-12|9|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-13|9|574|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-14|9|602|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-15|9|602|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-16|9|609|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-17|9|623|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-18|9|623|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-19|9|644|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-20|9|665|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-21|9|665|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-22|9|665|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-23|9|665|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-24|9|665|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-25|9|672|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-26|9|672|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-27|9|686|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-28|9|707|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-29|9|728|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-30|9|728|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-31|9|728|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-32|9|728|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-33|9|742|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-34|9|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-35|9|742|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-36|9|742|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-37|9|749|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-38|9|749|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-39|9|763|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-40|9|763|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-41|9|763|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-42|9|763|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-43|9|784|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-44|9|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-45|9|805|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-46|9|833|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-47|9|889|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-48|9|889|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-49|9|924|Other deterministic changes|Mammary gland|n/a|
11-1-9|XWa-Gy 1,AWXT_116.OA5NIH AWXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-9-50|9|1050|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-1|10|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-2|10|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-3|10|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-4|10|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-5|10|609|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-6|10|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-7|10|644|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-8|10|441|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-9|10|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-10|10|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-11|10|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-12|10|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-13|10|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-14|10|441|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-15|10|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-16|10|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-17|10|532|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-18|10|266|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-19|10|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-20|10|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-1|10|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-2|10|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-3|10|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-4|10|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-5|10|609|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-6|10|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-7|10|644|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-8|10|441|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-9|10|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-10|10|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-11|10|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-12|10|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-13|10|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-14|10|441|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-15|10|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-16|10|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-17|10|532|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-18|10|266|Other deterministic changes|Mammary gland|n/a|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-19|10|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-10|XWaOe-Gy 1,AWXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-10-20|10|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-1|11|273|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-2|11|441|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-3|11|518|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-4|11|763|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-5|11|826|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-6|11|826|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-7|11|833|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-8|11|861|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-9|11|910|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-10|11|931|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-11|11|945|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-12|11|952|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-13|11|959|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-14|11|973|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-15|11|1015|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-16|11|1015|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-17|11|1029|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-18|11|1043|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-1|11|273|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-2|11|441|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-3|11|518|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-4|11|763|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-5|11|826|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-6|11|826|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-7|11|833|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-8|11|861|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-9|11|910|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-10|11|931|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-11|11|945|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-12|11|952|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-13|11|959|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-14|11|973|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-15|11|1015|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-16|11|1015|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-17|11|1029|Other deterministic changes|Mammary gland|n/a|
11-1-11|XWaOv-Gy 1,AWXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-11-18|11|1043|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-1|12|532|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-2|12|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-3|12|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-4|12|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-5|12|336|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-6|12|504|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-7|12|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-8|12|539|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-9|12|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-10|12|357|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-11|12|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-12|12|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-13|12|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-14|12|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-15|12|490|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-16|12|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-17|12|490|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-18|12|595|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-19|12|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-1|12|532|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-2|12|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-3|12|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-4|12|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-5|12|336|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-6|12|504|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-7|12|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-8|12|539|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-9|12|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-10|12|357|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-11|12|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-12|12|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-13|12|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-14|12|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-15|12|490|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-16|12|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-17|12|490|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-18|12|595|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-19|12|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-1|12|532|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-2|12|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-3|12|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-4|12|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-5|12|336|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-6|12|504|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-7|12|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-8|12|539|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-9|12|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-10|12|357|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-11|12|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-12|12|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-13|12|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-14|12|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-15|12|490|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-16|12|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-17|12|490|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-18|12|595|Other deterministic changes|Mammary gland|n/a|
11-1-12|XWaOeOv-Gy 1,AWXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-12-19|12|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-1|13|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-2|13|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-3|13|504|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-4|13|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-5|13|511|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-6|13|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-7|13|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-8|13|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-9|13|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-10|13|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-11|13|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-12|13|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-13|13|581|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-14|13|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-15|13|588|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-16|13|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-17|13|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-18|13|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-19|13|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-20|13|672|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-21|13|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-22|13|693|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-23|13|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-24|13|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-25|13|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-26|13|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-27|13|756|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-28|13|763|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-29|13|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-30|13|784|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-31|13|791|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-32|13|833|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-33|13|847|Other deterministic changes|Mammary gland|n/a|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-34|13|847|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-13|XWa-Gy 4,AWXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|35 (35 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-13-35|13|882|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-1|14|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-2|14|294|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-3|14|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-4|14|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-5|14|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-6|14|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-7|14|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-8|14|392|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-9|14|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-10|14|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-11|14|483|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-12|14|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-13|14|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-14|14|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-15|14|294|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-16|14|371|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-17|14|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-18|14|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-19|14|280|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-20|14|154|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-1|14|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-2|14|294|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-3|14|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-4|14|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-5|14|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-6|14|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-7|14|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-8|14|392|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-9|14|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-10|14|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-11|14|483|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-12|14|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-13|14|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-14|14|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-15|14|294|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-16|14|371|Other deterministic changes|Mammary gland|n/a|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-17|14|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-18|14|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-19|14|280|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-14|XWaOe-Gy 4,AWXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-14-20|14|154|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-1|15|280|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-2|15|287|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-3|15|371|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-4|15|392|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-5|15|420|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-6|15|427|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-7|15|434|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-8|15|448|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-9|15|497|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-10|15|497|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-11|15|518|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-12|15|525|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-13|15|581|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-14|15|581|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-15|15|588|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-16|15|651|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-17|15|658|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-18|15|672|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-19|15|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-20|15|707|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-21|15|791|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-22|15|819|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-23|15|819|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-24|15|882|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-25|15|903|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-26|15|917|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-1|15|280|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-2|15|287|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-3|15|371|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-4|15|392|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-5|15|420|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-6|15|427|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-7|15|434|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-8|15|448|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-9|15|497|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-10|15|497|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-11|15|518|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-12|15|525|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-13|15|581|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-14|15|581|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-15|15|588|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-16|15|651|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-17|15|658|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-18|15|672|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-19|15|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-20|15|707|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-21|15|791|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-22|15|819|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-23|15|819|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-24|15|882|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-25|15|903|Other deterministic changes|Mammary gland|n/a|
11-1-15|XWaOv-Gy 4,AWXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|26 (26 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-15-26|15|917|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-1|16|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-2|16|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-3|16|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-4|16|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-5|16|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-6|16|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-7|16|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-8|16|420|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-9|16|301|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-10|16|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-11|16|322|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-12|16|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-13|16|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-14|16|322|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-15|16|308|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-16|16|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-17|16|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-18|16|357|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-19|16|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-20|16|336|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-1|16|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-2|16|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-3|16|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-4|16|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-5|16|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-6|16|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-7|16|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-8|16|420|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-9|16|301|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-10|16|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-11|16|322|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-12|16|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-13|16|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-14|16|322|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-15|16|308|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-16|16|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-17|16|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-18|16|357|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-19|16|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-20|16|336|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-1|16|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-2|16|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-3|16|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-4|16|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-5|16|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-6|16|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-7|16|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-8|16|420|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-9|16|301|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-10|16|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-11|16|322|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-12|16|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-13|16|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-14|16|322|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-15|16|308|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-16|16|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-17|16|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-18|16|357|Other deterministic changes|Mammary gland|n/a|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-19|16|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-16|XWaOeOv-Gy 4,AWXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-16-20|16|336|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-1|17|476|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-2|17|490|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-3|17|497|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-4|17|504|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-5|17|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-6|17|525|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-7|17|560|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-8|17|567|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-9|17|574|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-10|17|588|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-11|17|595|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-12|17|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-13|17|602|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-14|17|602|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-15|17|609|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-16|17|609|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-17|17|609|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-18|17|609|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-19|17|616|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-20|17|637|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-21|17|637|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-22|17|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-23|17|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-24|17|637|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-25|17|644|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-26|17|644|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-27|17|644|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-28|17|658|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-29|17|658|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-30|17|665|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-31|17|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-32|17|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-33|17|693|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-34|17|693|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-35|17|693|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-36|17|721|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-37|17|728|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-38|17|728|Other deterministic changes|Mammary gland|n/a|
11-1-17|N.5Wa-Gy 0.05,AWHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-17-39|17|770|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-1|18|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-2|18|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-3|18|476|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-4|18|350|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-5|18|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-6|18|721|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-7|18|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-8|18|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-9|18|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-10|18|518|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-11|18|448|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-12|18|343|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-13|18|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-14|18|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-15|18|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-16|18|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-17|18|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-18|18|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-19|18|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-20|18|714|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-21|18|868|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-22|18|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-23|18|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-24|18|490|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-25|18|574|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-26|18|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-27|18|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-28|18|749|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-29|18|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-30|18|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 218 - neoplasm|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-31|18|455|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-32|18|728|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-33|18|553|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-34|18|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-35|18|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-36|18|546|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-37|18|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-38|18|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-39|18|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-40|18|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-1|18|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-2|18|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-3|18|476|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-4|18|350|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-5|18|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-6|18|721|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-7|18|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-8|18|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-9|18|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-10|18|518|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-11|18|448|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-12|18|343|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-13|18|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-14|18|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-15|18|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-16|18|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-17|18|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-18|18|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-19|18|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-20|18|714|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-21|18|868|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-22|18|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-23|18|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-24|18|490|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-25|18|574|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-26|18|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-27|18|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-28|18|749|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-29|18|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-30|18|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 218 - neoplasm|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-31|18|455|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-32|18|728|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-33|18|553|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-34|18|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-35|18|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-36|18|546|Other deterministic changes|Mammary gland|n/a|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-37|18|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-38|18|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-39|18|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-18|N.5WaOe-Gy 0.05,AWHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-18-40|18|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-1|19|245|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-2|19|315|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-3|19|385|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-4|19|462|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-5|19|462|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-6|19|497|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-7|19|525|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-8|19|567|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-9|19|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-10|19|595|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-11|19|602|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-12|19|623|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-13|19|651|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-14|19|665|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-15|19|735|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-16|19|735|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-17|19|735|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-18|19|756|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-19|19|756|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-20|19|770|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-21|19|784|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-22|19|784|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-23|19|784|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-24|19|798|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-25|19|798|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-26|19|805|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-27|19|805|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-28|19|805|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-29|19|833|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-30|19|840|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-31|19|840|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-32|19|847|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-33|19|854|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-34|19|861|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-35|19|861|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-36|19|868|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-37|19|980|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-38|19|980|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-1|19|245|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-2|19|315|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-3|19|385|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-4|19|462|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-5|19|462|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-6|19|497|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-7|19|525|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-8|19|567|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-9|19|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-10|19|595|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-11|19|602|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-12|19|623|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-13|19|651|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-14|19|665|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-15|19|735|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-16|19|735|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-17|19|735|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-18|19|756|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-19|19|756|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-20|19|770|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-21|19|784|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-22|19|784|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-23|19|784|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-24|19|798|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-25|19|798|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-26|19|805|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-27|19|805|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-28|19|805|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-29|19|833|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-30|19|840|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-31|19|840|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-32|19|847|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-33|19|854|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-34|19|861|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-35|19|861|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-36|19|868|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-37|19|980|Other deterministic changes|Mammary gland|n/a|
11-1-19|N.5WaOv-Gy 0.05,AWHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-19-38|19|980|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-1|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-2|20|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-3|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-4|20|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-5|20|441|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-6|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-7|20|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-8|20|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-9|20|476|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-10|20|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-11|20|434|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-12|20|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-13|20|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-14|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-15|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-16|20|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-17|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-18|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-19|20|448|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-20|20|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-21|20|532|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-22|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-23|20|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-24|20|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-25|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-26|20|483|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-27|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-28|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-29|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-30|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-31|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-32|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-33|20|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-34|20|560|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-35|20|532|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-36|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-37|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-38|20|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-39|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-40|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-1|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-2|20|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-3|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-4|20|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-5|20|441|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-6|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-7|20|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-8|20|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-9|20|476|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-10|20|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-11|20|434|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-12|20|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-13|20|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-14|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-15|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-16|20|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-17|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-18|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-19|20|448|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-20|20|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-21|20|532|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-22|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-23|20|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-24|20|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-25|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-26|20|483|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-27|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-28|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-29|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-30|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-31|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-32|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-33|20|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-34|20|560|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-35|20|532|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-36|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-37|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-38|20|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-39|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-40|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-1|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-2|20|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-3|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-4|20|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-5|20|441|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-6|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-7|20|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-8|20|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-9|20|476|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-10|20|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-11|20|434|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-12|20|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-13|20|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-14|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-15|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-16|20|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-17|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-18|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-19|20|448|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-20|20|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-21|20|532|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-22|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-23|20|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-24|20|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-25|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-26|20|483|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-27|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-28|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-29|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-30|20|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-31|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-32|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-33|20|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-34|20|560|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-35|20|532|Other deterministic changes|Mammary gland|n/a|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-36|20|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-37|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-38|20|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-39|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-20|N.5WaOeOv-Gy 0.05,AWHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-20-40|20|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-1|21|203|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-2|21|357|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-3|21|378|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-4|21|455|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-5|21|469|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-6|21|469|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-7|21|469|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-8|21|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-9|21|490|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-10|21|532|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-11|21|560|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-12|21|574|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-13|21|574|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-14|21|581|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-15|21|630|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-16|21|672|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-17|21|700|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-18|21|812|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-19|21|847|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-1|21|203|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-2|21|357|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-3|21|378|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-4|21|455|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-5|21|469|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-6|21|469|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-7|21|469|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-8|21|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-9|21|490|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-10|21|532|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-11|21|560|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-12|21|574|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-13|21|574|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-14|21|581|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-15|21|630|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-16|21|672|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-17|21|700|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-18|21|812|Other deterministic changes|Mammary gland|n/a|
11-1-21|N.5WaOv-Gy 0.15,AWHT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-21-19|21|847|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-1|22|322|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-2|22|406|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-3|22|441|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-4|22|483|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-5|22|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-6|22|518|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-7|22|518|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-8|22|525|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-9|22|525|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-10|22|532|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-11|22|532|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-12|22|539|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-13|22|539|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-14|22|553|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-15|22|553|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-16|22|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-17|22|567|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-18|22|567|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-19|22|574|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-20|22|581|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-21|22|588|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-22|22|595|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-23|22|595|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-24|22|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-25|22|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-26|22|609|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-27|22|623|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-28|22|630|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-29|22|651|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-30|22|651|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-31|22|658|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-32|22|672|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-33|22|672|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-34|22|700|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-35|22|714|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-36|22|714|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-37|22|714|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-38|22|714|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-39|22|714|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-40|22|721|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-41|22|728|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-42|22|728|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-43|22|728|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-44|22|735|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-45|22|742|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-46|22|756|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-47|22|756|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-48|22|770|Other deterministic changes|Mammary gland|n/a|
11-1-22|N.5Wa-Gy 0.2,AWHT_116.HA5NIH AWHT_116.HA2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-22-49|22|861|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-1|23|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-2|23|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-3|23|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-4|23|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-5|23|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-6|23|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-7|23|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-8|23|476|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-9|23|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-10|23|560|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-11|23|231|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-12|23|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-13|23|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-14|23|378|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-15|23|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-16|23|434|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-17|23|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-18|23|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-19|23|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-20|23|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-1|23|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-2|23|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-3|23|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-4|23|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-5|23|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-6|23|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-7|23|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-8|23|476|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-9|23|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-10|23|560|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-11|23|231|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-12|23|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-13|23|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-14|23|378|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-15|23|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-16|23|434|Other deterministic changes|Mammary gland|n/a|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-17|23|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-18|23|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-19|23|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-23|N.5WaOe-Gy 0.2,AWHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-23-20|23|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-1|24|343|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-2|24|567|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-3|24|574|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-4|24|581|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-5|24|588|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-6|24|679|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-7|24|721|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-8|24|728|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-9|24|728|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-10|24|735|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-11|24|735|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-12|24|763|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-13|24|763|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-14|24|805|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-15|24|805|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-16|24|805|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-17|24|861|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-18|24|861|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-19|24|868|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-1|24|343|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-2|24|567|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-3|24|574|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-4|24|581|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-5|24|588|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-6|24|679|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-7|24|721|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-8|24|728|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-9|24|728|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-10|24|735|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-11|24|735|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-12|24|763|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-13|24|763|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-14|24|805|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-15|24|805|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-16|24|805|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-17|24|861|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-18|24|861|Other deterministic changes|Mammary gland|n/a|
11-1-24|N.5WaOv-Gy 0.2,AWHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-24-19|24|868|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-1|25|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-2|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-3|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-4|25|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-5|25|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-6|25|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-7|25|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-8|25|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-9|25|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-10|25|406|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-11|25|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-12|25|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-13|25|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-14|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-15|25|322|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-16|25|364|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-17|25|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-18|25|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-19|25|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-20|25|91|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-1|25|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-2|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-3|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-4|25|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-5|25|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-6|25|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-7|25|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-8|25|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-9|25|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-10|25|406|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-11|25|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-12|25|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-13|25|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-14|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-15|25|322|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-16|25|364|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-17|25|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-18|25|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-19|25|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-20|25|91|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-1|25|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-2|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-3|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-4|25|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-5|25|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-6|25|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-7|25|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-8|25|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-9|25|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-10|25|406|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-11|25|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-12|25|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-13|25|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-14|25|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-15|25|322|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-16|25|364|Other deterministic changes|Mammary gland|n/a|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-17|25|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-18|25|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-19|25|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-25|N.5WaOeOv-Gy 0.2,AWHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-25-20|25|91|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-1|26|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-2|26|455|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-3|26|455|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-4|26|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-5|26|476|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-6|26|490|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-7|26|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-8|26|504|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-9|26|511|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-10|26|525|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-11|26|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-12|26|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-13|26|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-14|26|546|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-15|26|553|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-16|26|588|Other deterministic changes|Mammary gland|n/a|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-17|26|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-18|26|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-19|26|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-26|N.5Wa-Gy 0.8,AWHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-26-20|26|665|Other deterministic changes|Mammary gland|n/a|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-1|27|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-2|27|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-3|27|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-4|27|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-5|27|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-6|27|546|Other deterministic changes|Mammary gland|n/a|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-7|27|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-8|27|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-9|27|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-10|27|231|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-11|27|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-12|27|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-13|27|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-14|27|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-15|27|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-16|27|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-17|27|308|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-18|27|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-19|27|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-20|27|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-1|27|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-2|27|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-3|27|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-4|27|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  7,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-5|27|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-6|27|546|Other deterministic changes|Mammary gland|n/a|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-7|27|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-8|27|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-9|27|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-10|27|231|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-11|27|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-12|27|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-13|27|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-14|27|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-15|27|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-16|27|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-17|27|308|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-18|27|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-19|27|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-27|N.5WaOe-Gy 0.8,AWHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-27-20|27|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-1|28|259|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-2|28|413|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-3|28|448|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-4|28|455|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-5|28|462|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-6|28|462|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-7|28|469|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-8|28|469|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-9|28|476|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-10|28|511|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-11|28|546|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-12|28|560|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-13|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-14|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-15|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-16|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-17|28|595|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-18|28|777|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-19|28|777|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-20|28|777|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-1|28|259|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-2|28|413|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-3|28|448|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-4|28|455|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-5|28|462|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-6|28|462|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-7|28|469|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-8|28|469|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-9|28|476|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-10|28|511|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-11|28|546|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-12|28|560|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-13|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-14|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-15|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-16|28|588|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-17|28|595|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-18|28|777|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-19|28|777|Other deterministic changes|Mammary gland|n/a|
11-1-28|N.5WaOv-Gy 0.8,AWHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-28-20|28|777|Other deterministic changes|Mammary gland|n/a|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-1|29|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-2|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-3|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-4|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-5|29|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-6|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-7|29|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-8|29|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-9|29|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-10|29|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-11|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-12|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-13|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-14|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-15|29|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-16|29|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-17|29|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-18|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-19|29|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.8|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-20|29|273|Other deterministic changes|Mammary gland|n/a|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-1|29|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-2|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-3|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-4|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-5|29|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-6|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-7|29|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-8|29|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-9|29|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-10|29|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-11|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-12|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-13|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-14|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-15|29|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-16|29|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-17|29|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-18|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-19|29|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-20|29|273|Other deterministic changes|Mammary gland|n/a|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-1|29|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-2|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-3|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-4|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-5|29|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-6|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-7|29|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-8|29|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-9|29|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-10|29|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-11|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-12|29|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-13|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-14|29|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-15|29|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-16|29|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-17|29|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-18|29|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-19|29|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-29|N.5WaOeOv-Gy 0.8,AWHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-29-20|29|273|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-1|30|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-2|30|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-3|30|504|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-4|30|539|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-5|30|595|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-6|30|602|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-7|30|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-8|30|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-9|30|637|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-10|30|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-11|30|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-12|30|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-13|30|714|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-14|30|721|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-15|30|728|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-16|30|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-17|30|749|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-18|30|756|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-19|30|763|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-20|30|770|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-21|30|777|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-22|30|777|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-23|30|777|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-24|30|784|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-25|30|798|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-26|30|826|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-27|30|826|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-28|30|875|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-29|30|882|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-30|30|903|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-31|30|903|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-32|30|910|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-33|30|910|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-34|30|917|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-35|30|952|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-36|30|966|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-37|30|966|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 218 - neoplasm|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-38|30|966|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-39|30|973|Other deterministic changes|Mammary gland|n/a|
11-1-30|N4Wa-Gy 0.1,AWIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-30-40|30|973|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-1|31|581|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-2|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-3|31|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 218 - neoplasm|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-4|31|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-5|31|546|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-6|31|595|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-7|31|455|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-8|31|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-9|31|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-10|31|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-11|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-12|31|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-13|31|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-14|31|315|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-15|31|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-16|31|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-17|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-18|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-19|31|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-20|31|462|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-21|31|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-22|31|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-23|31|448|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-24|31|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-25|31|511|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-26|31|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-27|31|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-28|31|490|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-29|31|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-30|31|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-31|31|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-32|31|434|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-33|31|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-34|31|518|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-35|31|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-36|31|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-37|31|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-38|31|532|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-39|31|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-40|31|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-1|31|581|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-2|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-3|31|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 218 - neoplasm|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-4|31|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-5|31|546|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-6|31|595|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-7|31|455|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-8|31|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-9|31|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-10|31|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-11|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-12|31|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-13|31|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-14|31|315|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-15|31|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-16|31|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-17|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-18|31|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-19|31|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-20|31|462|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-21|31|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-22|31|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-23|31|448|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-24|31|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-25|31|511|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-26|31|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-27|31|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-28|31|490|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-29|31|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-30|31|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-31|31|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-32|31|434|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-33|31|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-34|31|518|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-35|31|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-36|31|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-37|31|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-38|31|532|Other deterministic changes|Mammary gland|n/a|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-39|31|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-31|N4WaOe-Gy 0.1,AWIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-31-40|31|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-1|32|189|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-2|32|455|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-3|32|497|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-4|32|532|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-5|32|567|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-6|32|581|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-7|32|651|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-8|32|651|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-9|32|686|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-10|32|693|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-11|32|714|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-12|32|721|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-13|32|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-14|32|742|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-15|32|756|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-16|32|777|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-17|32|784|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-18|32|784|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-19|32|784|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-20|32|791|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-21|32|826|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-22|32|854|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-23|32|861|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-24|32|861|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-25|32|868|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-26|32|882|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-27|32|889|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-28|32|910|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-29|32|931|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-30|32|938|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-31|32|938|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-32|32|945|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-33|32|952|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-34|32|959|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-35|32|973|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-36|32|973|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-37|32|980|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-38|32|1064|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-39|32|1078|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-1|32|189|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-2|32|455|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-3|32|497|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-4|32|532|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-5|32|567|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-6|32|581|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-7|32|651|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-8|32|651|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-9|32|686|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-10|32|693|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-11|32|714|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-12|32|721|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-13|32|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-14|32|742|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-15|32|756|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-16|32|777|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-17|32|784|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-18|32|784|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-19|32|784|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-20|32|791|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-21|32|826|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-22|32|854|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-23|32|861|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-24|32|861|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-25|32|868|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-26|32|882|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-27|32|889|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-28|32|910|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-29|32|931|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-30|32|938|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-31|32|938|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-32|32|945|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-33|32|952|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-34|32|959|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-35|32|973|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-36|32|973|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-37|32|980|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-38|32|1064|Other deterministic changes|Mammary gland|n/a|
11-1-32|N4WaOv-Gy 0.1,AWIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-32-39|32|1078|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-1|33|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-2|33|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-3|33|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-4|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-5|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-6|33|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-7|33|210|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-8|33|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-9|33|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-10|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-11|33|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-12|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-13|33|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-14|33|252|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-15|33|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-16|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-17|33|427|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-18|33|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-19|33|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-20|33|546|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-21|33|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-22|33|539|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-23|33|539|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-24|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-25|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-26|33|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-27|33|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-28|33|483|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-29|33|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-30|33|525|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-31|33|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-32|33|644|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-33|33|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-34|33|623|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-35|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-36|33|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-37|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-38|33|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-39|33|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-40|33|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-1|33|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-2|33|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-3|33|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-4|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-5|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-6|33|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-7|33|210|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-8|33|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-9|33|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-10|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-11|33|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-12|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-13|33|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-14|33|252|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-15|33|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-16|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-17|33|427|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-18|33|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-19|33|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-20|33|546|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-21|33|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-22|33|539|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-23|33|539|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-24|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-25|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-26|33|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-27|33|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-28|33|483|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-29|33|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-30|33|525|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-31|33|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-32|33|644|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-33|33|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-34|33|623|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-35|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-36|33|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-37|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-38|33|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-39|33|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-40|33|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-1|33|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-2|33|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-3|33|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-4|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-5|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-6|33|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-7|33|210|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-8|33|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-9|33|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-10|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-11|33|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-12|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-13|33|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-14|33|252|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-15|33|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-16|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-17|33|427|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-18|33|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-19|33|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-20|33|546|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-21|33|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-22|33|539|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-23|33|539|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-24|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-25|33|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-26|33|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-27|33|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-28|33|483|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-29|33|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-30|33|525|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-31|33|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-32|33|644|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-33|33|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-34|33|623|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-35|33|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-36|33|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-37|33|609|Other deterministic changes|Mammary gland|n/a|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-38|33|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-39|33|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-33|N4WaOeOv-Gy 0.1,AWIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-33-40|33|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-1|34|637|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-2|34|700|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-3|34|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-4|34|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-5|34|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-6|34|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-7|34|504|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-8|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-9|34|448|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-10|34|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-11|34|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-12|34|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-13|34|546|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-14|34|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-15|34|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-16|34|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-17|34|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-18|34|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-19|34|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-20|34|469|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-21|34|434|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-22|34|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-23|34|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-24|34|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-25|34|574|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-26|34|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-27|34|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-28|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-29|34|581|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-30|34|511|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-31|34|427|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-32|34|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-33|34|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-34|34|567|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-35|34|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-36|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-37|34|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-38|34|581|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-39|34|448|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|1| 56|neutrons 1-10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-40|34|77|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-1|34|637|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-2|34|700|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-3|34|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-4|34|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-5|34|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-6|34|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-7|34|504|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-8|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-9|34|448|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-10|34|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-11|34|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-12|34|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-13|34|546|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-14|34|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-15|34|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-16|34|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-17|34|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-18|34|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-19|34|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-20|34|469|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-21|34|434|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-22|34|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-23|34|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-24|34|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-25|34|574|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-26|34|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-27|34|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-28|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-29|34|581|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-30|34|511|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-31|34|427|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-32|34|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-33|34|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-34|34|567|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-35|34|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-36|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-37|34|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-38|34|581|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-39|34|448|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-40|34|77|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-1|34|637|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-2|34|700|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-3|34|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-4|34|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-5|34|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-6|34|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-7|34|504|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-8|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-9|34|448|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-10|34|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-11|34|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-12|34|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-13|34|546|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-14|34|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-15|34|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-16|34|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-17|34|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-18|34|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-19|34|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-20|34|469|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-21|34|434|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-22|34|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-23|34|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-24|34|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-25|34|574|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-26|34|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-27|34|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-28|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-29|34|581|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-30|34|511|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-31|34|427|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-32|34|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-33|34|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-34|34|567|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-35|34|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-36|34|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-37|34|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-38|34|581|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-39|34|448|Other deterministic changes|Mammary gland|n/a|
11-1-34|N4WaOeOv-Gy 0.15,AWIT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-34-40|34|77|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-1|35|231|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-2|35|287|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-3|35|336|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-4|35|441|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-5|35|469|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-6|35|511|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-7|35|518|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-8|35|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-9|35|532|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-10|35|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-11|35|567|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-12|35|567|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-13|35|581|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-14|35|581|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-15|35|588|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-16|35|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-17|35|595|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-18|35|595|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-19|35|602|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-20|35|602|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-21|35|609|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-22|35|609|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-23|35|609|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-24|35|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-25|35|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-26|35|630|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-27|35|630|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-28|35|644|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-29|35|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-30|35|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-31|35|665|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-32|35|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-33|35|672|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-34|35|679|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-35|35|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-36|35|714|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-37|35|714|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-38|35|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-39|35|791|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-40|35|791|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-41|35|791|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-42|35|812|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-43|35|812|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-44|35|812|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-45|35|819|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-46|35|840|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-47|35|861|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-48|35|882|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-49|35|931|Other deterministic changes|Mammary gland|n/a|
11-1-35|N4Wa-Gy 0.3,AWIT_116.JA2NIH AWIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-35-50|35|952|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-1|36|378|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-2|36|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-3|36|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-4|36|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-5|36|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-6|36|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-7|36|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-8|36|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-9|36|525|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-10|36|378|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-11|36|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-12|36|588|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-13|36|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-14|36|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-15|36|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-16|36|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-17|36|336|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-18|36|371|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-19|36|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-20|36|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-1|36|378|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-2|36|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-3|36|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-4|36|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-5|36|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-6|36|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-7|36|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-8|36|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-9|36|525|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-10|36|378|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-11|36|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-12|36|588|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-13|36|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-14|36|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-15|36|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-16|36|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-17|36|336|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-18|36|371|Other deterministic changes|Mammary gland|n/a|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-19|36|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-36|N4WaOe-Gy 0.3,AWIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|50 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-36-20|36|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-1|37|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-2|37|630|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-3|37|707|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-4|37|721|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-5|37|735|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-6|37|777|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-7|37|805|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-8|37|819|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-9|37|826|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-10|37|826|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-11|37|840|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-12|37|840|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-13|37|868|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-14|37|875|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-15|37|889|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-16|37|917|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-17|37|952|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-18|37|987|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-19|37|987|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-20|37|105|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-1|37|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-2|37|630|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-3|37|707|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-4|37|721|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-5|37|735|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-6|37|777|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-7|37|805|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-8|37|819|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-9|37|826|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-10|37|826|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-11|37|840|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-12|37|840|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-13|37|868|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-14|37|875|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-15|37|889|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-16|37|917|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-17|37|952|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-18|37|987|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-19|37|987|Other deterministic changes|Mammary gland|n/a|
11-1-37|N4WaOv-Gy 0.3,AWIT_116.JC2NIH|2| 49|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-37-20|37|105|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-1|38|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-2|38|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-3|38|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-4|38|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-5|38|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-6|38|392|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-7|38|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-8|38|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-9|38|217|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-10|38|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-11|38|399|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-12|38|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-13|38|350|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-14|38|518|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-15|38|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-16|38|301|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-17|38|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-18|38|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-19|38|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-1|38|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-2|38|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-3|38|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-4|38|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-5|38|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-6|38|392|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-7|38|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-8|38|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-9|38|217|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-10|38|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-11|38|399|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-12|38|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-13|38|350|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-14|38|518|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-15|38|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-16|38|301|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-17|38|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-18|38|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-19|38|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-1|38|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-2|38|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-3|38|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-4|38|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-5|38|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-6|38|392|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-7|38|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-8|38|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-9|38|217|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-10|38|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-11|38|399|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-12|38|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-13|38|350|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-14|38|518|Other deterministic changes|Mammary gland|n/a|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-15|38|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-16|38|301|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-17|38|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-18|38|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-38|N4WaOeOv-Gy 0.5,AWIT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-38-19|38|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-1|39|245|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-2|39|280|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-3|39|322|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-4|39|392|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-5|39|399|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-6|39|413|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-7|39|420|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-8|39|420|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-9|39|441|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-10|39|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-11|39|518|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-12|39|525|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-13|39|525|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-14|39|532|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-15|39|539|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-16|39|546|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-17|39|581|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-18|39|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-19|39|602|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-20|39|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-21|39|602|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-22|39|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-23|39|630|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-24|39|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-25|39|630|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-26|39|630|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-27|39|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-28|39|651|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-29|39|658|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-30|39|672|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-31|39|679|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-32|39|686|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-33|39|693|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-34|39|693|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-35|39|693|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-36|39|700|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-37|39|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-38|39|742|Other deterministic changes|Mammary gland|n/a|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-39|39|749|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-39|N4Wa-Gy 1,AWIT_116.OA3NIH AWIT_116.OA6NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-39-40|39|112|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-1|40|364|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-2|40|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-3|40|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-4|40|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-5|40|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-6|40|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-7|40|483|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-8|40|511|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-9|40|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-10|40|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-11|40|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-12|40|483|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-13|40|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-14|40|399|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-15|40|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-16|40|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-17|40|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-18|40|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-19|40|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-20|40|98|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-1|40|364|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-2|40|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-3|40|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-4|40|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-5|40|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-6|40|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-7|40|483|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-8|40|511|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-9|40|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-10|40|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-11|40|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-12|40|483|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-13|40|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-14|40|399|Other deterministic changes|Mammary gland|n/a|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-15|40|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-16|40|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-17|40|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-18|40|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-19|40|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-40|N4WaOe-Gy 1,AWIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-40-20|40|98|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-1|41|210|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-2|41|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 218 - neoplasm|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-3|41|448|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-4|41|483|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-5|41|511|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-6|41|553|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-7|41|602|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-8|41|686|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-9|41|721|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-10|41|742|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-11|41|742|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-12|41|756|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-13|41|756|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-14|41|763|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-15|41|763|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-16|41|770|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-17|41|833|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-18|41|882|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-19|41|882|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-20|41|952|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-1|41|210|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-2|41|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 218 - neoplasm|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-3|41|448|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-4|41|483|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-5|41|511|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-6|41|553|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-7|41|602|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-8|41|686|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-9|41|721|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-10|41|742|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-11|41|742|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-12|41|756|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-13|41|756|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-14|41|763|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-15|41|763|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-16|41|770|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-17|41|833|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-18|41|882|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-19|41|882|Other deterministic changes|Mammary gland|n/a|
11-1-41|N4WaOv-Gy 1,AWIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-41-20|41|952|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-1|42|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-2|42|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-3|42|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-4|42|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-5|42|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-6|42|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-7|42|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-8|42|539|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-9|42|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-10|42|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-11|42|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-12|42|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-13|42|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-14|42|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-15|42|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-16|42|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-17|42|427|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-18|42|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-19|42|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-1|42|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-2|42|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-3|42|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-4|42|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-5|42|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-6|42|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-7|42|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-8|42|539|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-9|42|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-10|42|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-11|42|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-12|42|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-13|42|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-14|42|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-15|42|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-16|42|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-17|42|427|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-18|42|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-19|42|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-1|42|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-2|42|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-3|42|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-4|42|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-5|42|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-6|42|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-7|42|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-8|42|539|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-9|42|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-10|42|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-11|42|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-12|42|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-13|42|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-14|42|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-15|42|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-16|42|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-17|42|427|Other deterministic changes|Mammary gland|n/a|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-18|42|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-42|N4WaOeOv-Gy 1,AWIT_116.OD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-42-19|42|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-1|43|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-2|43|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-3|43|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-4|43|490|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-5|43|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-6|43|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-7|43|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-8|43|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-9|43|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-10|43|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-11|43|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-12|43|427|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-13|43|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-14|43|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-15|43|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-16|43|238|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-17|43|392|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-18|43|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-19|43|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-20|43|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-1|43|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-2|43|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-3|43|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-4|43|490|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-5|43|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-6|43|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-7|43|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-8|43|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-9|43|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-10|43|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-11|43|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-12|43|427|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-13|43|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-14|43|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-15|43|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-16|43|238|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-17|43|392|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-18|43|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-19|43|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-20|43|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-1|43|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-2|43|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-3|43|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-4|43|490|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-5|43|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-6|43|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-7|43|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-8|43|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-9|43|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-10|43|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-11|43|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-12|43|427|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-13|43|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-14|43|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-15|43|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-16|43|238|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-17|43|392|Other deterministic changes|Mammary gland|n/a|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-18|43|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-19|43|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-43|N4WaOeOv-Gy 1.5,AWIT_116.PD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-43-20|43|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-1|44|476|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-2|44|574|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-3|44|609|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-4|44|623|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-5|44|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-6|44|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-7|44|665|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-8|44|665|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-9|44|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-10|44|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-11|44|714|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-12|44|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-13|44|749|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-14|44|749|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-15|44|756|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-16|44|770|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-17|44|777|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-18|44|777|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-19|44|798|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-20|44|798|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-21|44|798|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-22|44|805|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-23|44|819|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-24|44|819|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-25|44|826|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-26|44|826|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-27|44|861|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-28|44|861|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-29|44|875|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-30|44|875|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-31|44|889|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-32|44|896|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-33|44|896|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-34|44|910|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-35|44|910|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-36|44|924|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-37|44|924|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-38|44|924|Other deterministic changes|Mammary gland|n/a|
11-1-44|N15Wa-Gy 0.15,AWJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-44-39|44|1008|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-1|45|357|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-2|45|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-3|45|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-4|45|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-5|45|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-6|45|532|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-7|45|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-8|45|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-9|45|483|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-10|45|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-11|45|427|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-12|45|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-13|45|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-14|45|343|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-15|45|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-16|45|511|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-17|45|399|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-18|45|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-19|45|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-20|45|511|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-21|45|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-22|45|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-23|45|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-24|45|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-25|45|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-26|45|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-27|45|616|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-28|45|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-29|45|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-30|45|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-31|45|483|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-32|45|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-33|45|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-34|45|392|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-35|45|280|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-36|45|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-37|45|357|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-38|45|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-39|45|112|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-40|45|154|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-1|45|357|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-2|45|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-3|45|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-4|45|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-5|45|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-6|45|532|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-7|45|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-8|45|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-9|45|483|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-10|45|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-11|45|427|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-12|45|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-13|45|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-14|45|343|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-15|45|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-16|45|511|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-17|45|399|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-18|45|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-19|45|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-20|45|511|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-21|45|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-22|45|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-23|45|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-24|45|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-25|45|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-26|45|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-27|45|616|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-28|45|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-29|45|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-30|45|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-31|45|483|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-32|45|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-33|45|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-34|45|392|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-35|45|280|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-36|45|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-37|45|357|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-38|45|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-39|45|112|Other deterministic changes|Mammary gland|n/a|
11-1-45|N15WaOe-Gy 0.15,AWJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-45-40|45|154|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-1|46|350|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-2|46|350|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-3|46|623|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-4|46|630|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-5|46|651|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-6|46|679|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-7|46|679|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-8|46|707|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-9|46|707|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-10|46|721|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-11|46|721|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-12|46|728|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-13|46|728|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-14|46|735|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-15|46|749|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-16|46|770|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-17|46|798|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-18|46|875|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-19|46|889|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-20|46|896|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-21|46|903|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-22|46|924|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-23|46|931|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-24|46|938|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-25|46|938|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-26|46|959|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-27|46|959|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-28|46|959|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-29|46|987|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-30|46|1001|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-31|46|1029|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-32|46|1050|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-33|46|1064|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-34|46|1064|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-35|46|1064|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-36|46|1071|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-37|46|1071|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-38|46|1071|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-1|46|350|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-2|46|350|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-3|46|623|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-4|46|630|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-5|46|651|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-6|46|679|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-7|46|679|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-8|46|707|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-9|46|707|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-10|46|721|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-11|46|721|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-12|46|728|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-13|46|728|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-14|46|735|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-15|46|749|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-16|46|770|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-17|46|798|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-18|46|875|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-19|46|889|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-20|46|896|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-21|46|903|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-22|46|924|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-23|46|931|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-24|46|938|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-25|46|938|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-26|46|959|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-27|46|959|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-28|46|959|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-29|46|987|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-30|46|1001|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-31|46|1029|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-32|46|1050|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-33|46|1064|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-34|46|1064|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-35|46|1064|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-36|46|1071|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-37|46|1071|Other deterministic changes|Mammary gland|n/a|
11-1-46|N15WaOv-Gy 0.15,AWJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-46-38|46|1071|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-1|47|357|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-2|47|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-3|47|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-4|47|378|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-5|47|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-6|47|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-7|47|497|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-8|47|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-9|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-10|47|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-11|47|469|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-12|47|441|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-13|47|189|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-14|47|434|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-15|47|462|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-16|47|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-17|47|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-18|47|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-19|47|546|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-20|47|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-21|47|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-22|47|616|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-23|47|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-24|47|504|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-25|47|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-26|47|301|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-27|47|392|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-28|47|385|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-29|47|413|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-30|47|525|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-31|47|644|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-32|47|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-33|47|630|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-34|47|406|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-35|47|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-36|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-37|47|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-38|47|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-39|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-40|47|511|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-1|47|357|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-2|47|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-3|47|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-4|47|378|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-5|47|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-6|47|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-7|47|497|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-8|47|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-9|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-10|47|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-11|47|469|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-12|47|441|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-13|47|189|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-14|47|434|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-15|47|462|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-16|47|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-17|47|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-18|47|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-19|47|546|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-20|47|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-21|47|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-22|47|616|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-23|47|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-24|47|504|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-25|47|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-26|47|301|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-27|47|392|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-28|47|385|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-29|47|413|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-30|47|525|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-31|47|644|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-32|47|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-33|47|630|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-34|47|406|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-35|47|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-36|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-37|47|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-38|47|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-39|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-40|47|511|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-1|47|357|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-2|47|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-3|47|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-4|47|378|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-5|47|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-6|47|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-7|47|497|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-8|47|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-9|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-10|47|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-11|47|469|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-12|47|441|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-13|47|189|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-14|47|434|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-15|47|462|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-16|47|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-17|47|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-18|47|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-19|47|546|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-20|47|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-21|47|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-22|47|616|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-23|47|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-24|47|504|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-25|47|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-26|47|301|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-27|47|392|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-28|47|385|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-29|47|413|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-30|47|525|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-31|47|644|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-32|47|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-33|47|630|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-34|47|406|Other deterministic changes|Mammary gland|n/a|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-35|47|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-36|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-37|47|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-38|47|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-39|47|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-47|N15aOeOv-Gy 0.15,AWJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-47-40|47|511|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-1|48|336|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-2|48|357|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-3|48|469|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-4|48|483|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-5|48|497|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-6|48|497|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-7|48|511|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-8|48|511|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-9|48|511|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-10|48|518|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-11|48|518|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-12|48|525|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-13|48|546|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-14|48|546|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-15|48|567|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-16|48|588|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-17|48|595|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-18|48|616|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-19|48|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-20|48|637|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-21|48|644|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-22|48|644|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-23|48|658|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-24|48|658|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-25|48|658|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-26|48|658|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-27|48|672|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-28|48|679|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-29|48|686|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-30|48|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-31|48|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-32|48|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-33|48|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-34|48|707|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-35|48|707|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-36|48|714|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-37|48|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-38|48|721|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-39|48|721|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-40|48|721|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-41|48|728|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-42|48|728|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-43|48|735|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-44|48|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-45|48|770|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-46|48|805|Other deterministic changes|Mammary gland|n/a|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-47|48|812|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-48|48|861|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-49|48|861|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-48|N15Wa-Gy 0.5,AWJT_116.MA5NIH AWJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-48-50|48|917|Other deterministic changes|Mammary gland|n/a|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-1|49|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-2|49|252|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-3|49|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-4|49|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-5|49|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-6|49|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-7|49|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-8|49|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-9|49|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-10|49|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-11|49|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-12|49|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-13|49|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-14|49|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-15|49|455|Other deterministic changes|Mammary gland|n/a|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-16|49|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-17|49|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-18|49|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-19|49|504|Other deterministic changes|Mammary gland|n/a|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-20|49|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-1|49|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-2|49|252|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-3|49|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-4|49|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-5|49|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-6|49|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-7|49|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-8|49|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-9|49|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-10|49|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-11|49|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-12|49|336|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-13|49|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-14|49|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-15|49|455|Other deterministic changes|Mammary gland|n/a|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-16|49|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-17|49|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-18|49|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-19|49|504|Other deterministic changes|Mammary gland|n/a|
11-1-49|N15WaOe-Gy 0.5,AWJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-49-20|49|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-1|50|490|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-2|50|546|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-3|50|567|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-4|50|567|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-5|50|567|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-6|50|637|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-7|50|658|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-8|50|714|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-9|50|770|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-10|50|784|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-11|50|833|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-12|50|882|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-13|50|882|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-14|50|896|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-15|50|931|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-16|50|945|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-17|50|987|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-18|50|1001|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-19|50|1008|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-1|50|490|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-2|50|546|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-3|50|567|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-4|50|567|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-5|50|567|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-6|50|637|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-7|50|658|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-8|50|714|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-9|50|770|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-10|50|784|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-11|50|833|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-12|50|882|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-13|50|882|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-14|50|896|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-15|50|931|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-16|50|945|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-17|50|987|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-18|50|1001|Other deterministic changes|Mammary gland|n/a|
11-1-50|N15WaOv-Gy 0.5,AWJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-50-19|50|1008|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-1|51|427|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-2|51|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-3|51|420|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-4|51|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-5|51|462|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-6|51|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-7|51|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-8|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-9|51|420|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-10|51|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-11|51|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-12|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-13|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-14|51|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-15|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-16|51|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-17|51|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-18|51|427|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-19|51|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-20|51|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-1|51|427|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-2|51|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-3|51|420|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-4|51|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-5|51|462|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-6|51|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-7|51|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-8|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-9|51|420|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-10|51|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-11|51|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-12|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-13|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-14|51|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-15|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-16|51|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-17|51|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-18|51|427|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-19|51|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-20|51|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-1|51|427|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-2|51|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-3|51|420|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-4|51|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-5|51|462|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-6|51|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-7|51|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-8|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-9|51|420|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-10|51|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-11|51|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-12|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-13|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-14|51|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-15|51|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-16|51|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-17|51|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-18|51|427|Other deterministic changes|Mammary gland|n/a|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-19|51|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-51|N15aOeOv-Gy 0.5,AWJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-51-20|51|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-1|52|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-2|52|462|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-3|52|483|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-4|52|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-5|52|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-6|52|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-7|52|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-8|52|539|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-9|52|567|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-10|52|595|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-11|52|658|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-12|52|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 266 - fibroadenoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-13|52|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-14|52|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-15|52|721|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-16|52|742|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-17|52|749|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-18|52|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-19|52|791|Other deterministic changes|Mammary gland|n/a|
11-1-52|N15Wa-Gy 1.5,AWJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-52-20|52|896|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-1|53|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-2|53|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-3|53|399|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-4|53|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-5|53|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-6|53|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-7|53|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-8|53|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-9|53|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-10|53|553|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-11|53|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-12|53|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-13|53|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-14|53|385|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-15|53|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-16|53|273|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-17|53|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-18|53|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-19|53|434|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|not applicable or not supplied| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-20|53|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-1|53|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-2|53|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-3|53|399|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-4|53|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-5|53|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-6|53|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-7|53|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-8|53|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-9|53|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-10|53|553|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-11|53|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-12|53|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-13|53|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-14|53|385|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-15|53|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-16|53|273|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-17|53|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-18|53|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-19|53|434|Other deterministic changes|Mammary gland|n/a|
11-1-53|N15WaOe-Gy 1.5,AWJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-53-20|53|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-1|54|259|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-2|54|308|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-3|54|357|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-4|54|364|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-5|54|364|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-6|54|385|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-7|54|413|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-8|54|427|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-9|54|455|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-10|54|462|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-11|54|469|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-12|54|469|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-13|54|469|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-14|54|518|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-15|54|539|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-16|54|546|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-17|54|574|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-18|54|581|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-19|54|581|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-20|54|588|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-21|54|595|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-22|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-23|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-24|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-25|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-26|54|616|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-27|54|623|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-28|54|651|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-29|54|679|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-30|54|686|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-31|54|770|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-32|54|784|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-33|54|826|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-34|54|847|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-35|54|861|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-36|54|924|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-37|54|938|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-38|54|938|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-1|54|259|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-2|54|308|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-3|54|357|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-4|54|364|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-5|54|364|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-6|54|385|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-7|54|413|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-8|54|427|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-9|54|455|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-10|54|462|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-11|54|469|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-12|54|469|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-13|54|469|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-14|54|518|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-15|54|539|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-16|54|546|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-17|54|574|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-18|54|581|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-19|54|581|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-20|54|588|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-21|54|595|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-22|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-23|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-24|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-25|54|609|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-26|54|616|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-27|54|623|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-28|54|651|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-29|54|679|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-30|54|686|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-31|54|770|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-32|54|784|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-33|54|826|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-34|54|847|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-35|54|861|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-36|54|924|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-37|54|938|Other deterministic changes|Mammary gland|n/a|
11-1-54|N15WaOv-Gy 1.5,AWJT_116.PC5NIH AWJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-54-38|54|938|Other deterministic changes|Mammary gland|n/a|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-1|55|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-2|55|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-3|55|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-4|55|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-5|55|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-6|55|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-7|55|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-8|55|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-9|55|357|Other deterministic changes|Mammary gland|n/a|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-10|55|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-11|55|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-12|55|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-13|55|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-14|55|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-15|55|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-16|55|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-17|55|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-18|55|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-19|55|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-1|55|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-2|55|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-3|55|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-4|55|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-5|55|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-6|55|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-7|55|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-8|55|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-9|55|357|Other deterministic changes|Mammary gland|n/a|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-10|55|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-11|55|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-12|55|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-13|55|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-14|55|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-15|55|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-16|55|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-17|55|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-18|55|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-19|55|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-1|55|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-2|55|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-3|55|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-4|55|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-5|55|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-6|55|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-7|55|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-8|55|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-9|55|357|Other deterministic changes|Mammary gland|n/a|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-10|55|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-11|55|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-12|55|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-13|55|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-14|55|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-15|55|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-16|55|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-17|55|322|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-18|55|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-55|N15aOeOv-Gy 1.5,AWJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, WAG/RIJ|Female|Young Adult|visible/palpable tumors|11-1-55-19|55|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-1|56|399|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-2|56|406|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-3|56|413|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-4|56|413|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-5|56|448|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-6|56|455|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-7|56|462|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-8|56|476|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-9|56|476|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-10|56|497|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-11|56|497|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-12|56|511|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-13|56|511|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-14|56|511|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-15|56|532|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-16|56|539|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-17|56|539|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-18|56|546|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-19|56|546|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-20|56|553|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-21|56|553|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-22|56|560|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-23|56|560|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-24|56|560|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-25|56|567|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-26|56|567|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-27|56|567|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-28|56|567|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-29|56|567|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-30|56|567|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-31|56|581|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-32|56|588|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-33|56|595|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-34|56|609|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-35|56|609|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-36|56|616|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-37|56|616|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-38|56|623|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-39|56|637|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-40|56|637|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-41|56|644|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-42|56|651|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-43|56|651|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-44|56|651|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-45|56|665|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-46|56|665|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-47|56|665|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-48|56|686|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-49|56|686|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-50|56|686|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-51|56|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-52|56|707|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-53|56|728|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-54|56|742|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-55|56|742|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-56|56|742|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-57|56|742|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-58|56|749|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-59|56|756|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-60|56|777|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-61|56|777|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-62|56|784|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-63|56|798|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-64|56|805|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-65|56|805|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-66|56|826|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-67|56|826|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-68|56|826|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-69|56|826|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-70|56|826|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-71|56|833|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-72|56|840|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-73|56|847|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-74|56|861|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-75|56|889|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-76|56|903|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-77|56|980|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-78|56|1197|Other deterministic changes|Mammary gland|n/a|
11-1-56|Sd-Gy 0,AS00_007.0A5NIH AS00_007.0A0NIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|79 (79 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-56-79|56|1197|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-1|57|455|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-2|57|602|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-3|57|476|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-4|57|574|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-5|57|497|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-6|57|469|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-7|57|567|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-8|57|476|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-9|57|441|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-10|57|483|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-11|57|483|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-12|57|686|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-13|57|616|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-14|57|602|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-15|57|504|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-16|57|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-17|57|525|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-18|57|560|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-19|57|427|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-20|57|483|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-21|57|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-22|57|371|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-23|57|357|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-24|57|399|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-25|57|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-26|57|567|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-27|57|364|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-28|57|553|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-29|57|553|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-30|57|511|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-31|57|448|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-32|57|609|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-33|57|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-34|57|609|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-35|57|462|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-36|57|455|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-37|57|553|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-38|57|609|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-39|57|609|Other deterministic changes|Mammary gland|n/a|
11-1-57|SdOe-Gy 0,AS00_007.0B0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-57-40|57|497|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-1|58|259|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-2|58|350|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-3|58|427|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-4|58|427|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-5|58|448|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-6|58|448|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-7|58|448|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-8|58|455|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-9|58|455|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-10|58|483|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-11|58|483|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-12|58|518|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-13|58|532|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-14|58|532|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-15|58|546|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-16|58|546|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-17|58|553|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-18|58|574|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-19|58|595|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-20|58|595|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-21|58|609|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-22|58|609|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-23|58|609|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-24|58|623|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-25|58|623|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-26|58|630|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-27|58|637|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-28|58|637|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-29|58|637|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-30|58|637|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-31|58|637|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-32|58|637|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-33|58|644|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-34|58|644|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-35|58|644|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-36|58|651|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-37|58|665|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-38|58|679|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-39|58|679|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-40|58|679|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-41|58|679|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-42|58|686|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-43|58|693|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-44|58|700|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-45|58|700|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-46|58|735|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-47|58|763|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-48|58|784|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-49|58|784|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-50|58|798|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-51|58|812|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-52|58|819|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-53|58|826|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-54|58|833|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-55|58|840|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-56|58|847|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-57|58|847|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-58|58|847|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-59|58|854|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-60|58|861|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-61|58|868|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-62|58|875|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-63|58|875|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-64|58|875|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-65|58|882|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-66|58|882|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-67|58|882|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-68|58|889|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-69|58|896|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-70|58|903|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-71|58|910|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-72|58|917|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-73|58|917|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-74|58|924|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-75|58|924|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-76|58|931|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-77|58|945|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-78|58|952|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-79|58|959|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-80|58|959|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-81|58|973|Other deterministic changes|Mammary gland|n/a|
11-1-58|SdOv-Gy 0,AS00_007.0C5NIH AS00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|82 (82 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-58-82|58|973|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-1|59|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  9,MPATH: 218 - neoplasm|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-2|59|420|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-3|59|588|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-4|59|518|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-5|59|469|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-6|59|553|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-7|59|518|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-8|59|553|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-9|59|455|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-10|59|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-11|59|399|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-12|59|441|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-13|59|504|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-14|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-15|59|511|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-16|59|378|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-17|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-18|59|336|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-19|59|392|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-20|59|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-21|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-22|59|392|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-23|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-24|59|567|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-25|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-26|59|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-27|59|546|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-28|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-29|59|567|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-30|59|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-31|59|546|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-32|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-33|59|588|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-34|59|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-35|59|427|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-36|59|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-37|59|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-38|59|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-39|59|658|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-1|59|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  9,MPATH: 218 - neoplasm|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-2|59|420|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-3|59|588|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-4|59|518|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-5|59|469|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-6|59|553|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-7|59|518|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-8|59|553|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-9|59|455|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-10|59|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-11|59|399|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-12|59|441|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-13|59|504|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-14|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-15|59|511|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-16|59|378|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-17|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-18|59|336|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-19|59|392|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-20|59|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-21|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-22|59|392|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-23|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-24|59|567|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-25|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-26|59|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-27|59|546|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-28|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-29|59|567|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-30|59|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-31|59|546|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-32|59|448|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-33|59|588|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-34|59|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-35|59|427|Other deterministic changes|Mammary gland|n/a|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-36|59|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-37|59|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-38|59|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-59|SdOeOv-Gy 0,AS00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-59-39|59|658|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-1|60|441|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-2|60|560|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-3|60|581|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-4|60|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-5|60|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-6|60|630|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-7|60|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-8|60|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-9|60|679|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-10|60|693|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-11|60|693|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-12|60|693|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-13|60|700|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-14|60|700|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-15|60|742|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-16|60|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-17|60|749|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-18|60|763|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-19|60|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-20|60|770|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-21|60|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-22|60|777|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-23|60|784|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-24|60|784|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-25|60|791|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-26|60|798|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 218 - neoplasm|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-27|60|812|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-28|60|812|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-29|60|819|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-30|60|826|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-31|60|833|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-32|60|840|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-33|60|854|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-34|60|875|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-35|60|875|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-36|60|889|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-37|60|896|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-38|60|931|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-39|60|945|Other deterministic changes|Mammary gland|n/a|
11-1-60|XSd-Gy 0.1,ASXT_116.EA1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-60-40|60|980|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 266 - fibroadenoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-1|61|714|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-2|61|406|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-3|61|490|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-4|61|427|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-5|61|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-6|61|504|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-7|61|434|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-8|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-9|61|581|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-10|61|504|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-11|61|553|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-12|61|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-13|61|378|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-14|61|469|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-15|61|399|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-16|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-17|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-18|61|539|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-19|61|490|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-20|61|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-21|61|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  9,MPATH: 266 - fibroadenoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-22|61|483|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-23|61|532|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-24|61|455|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-25|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-26|61|455|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-27|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-28|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-29|61|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-30|61|532|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-31|61|490|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-32|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-33|61|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-34|61|462|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-35|61|280|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-36|61|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-37|61|525|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-38|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-39|61|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-1|61|714|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-2|61|406|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-3|61|490|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-4|61|427|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-5|61|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-6|61|504|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-7|61|434|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-8|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-9|61|581|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-10|61|504|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-11|61|553|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-12|61|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-13|61|378|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-14|61|469|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-15|61|399|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-16|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-17|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-18|61|539|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-19|61|490|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-20|61|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-21|61|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  9,MPATH: 266 - fibroadenoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-22|61|483|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-23|61|532|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-24|61|455|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-25|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-26|61|455|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-27|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-28|61|511|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-29|61|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-30|61|532|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-31|61|490|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-32|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-33|61|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-34|61|462|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-35|61|280|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-36|61|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-37|61|525|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-38|61|567|Other deterministic changes|Mammary gland|n/a|
11-1-61|XSdOe-Gy 0.1,ASXT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-61-39|61|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-1|62|609|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-2|62|616|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-3|62|644|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-4|62|651|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-5|62|651|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-6|62|658|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-7|62|665|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-8|62|672|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-9|62|672|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-10|62|679|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-11|62|693|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-12|62|693|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-13|62|700|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-14|62|728|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-15|62|728|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-16|62|735|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-17|62|756|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-18|62|763|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-19|62|763|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-20|62|770|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-21|62|777|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-22|62|784|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-23|62|805|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-24|62|812|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-25|62|819|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-26|62|819|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-27|62|833|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-28|62|840|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-29|62|840|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-30|62|847|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-31|62|861|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-32|62|861|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-33|62|882|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-34|62|896|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-35|62|903|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-36|62|917|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-37|62|938|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-38|62|966|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-39|62|1015|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-1|62|609|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-2|62|616|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-3|62|644|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-4|62|651|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-5|62|651|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-6|62|658|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-7|62|665|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-8|62|672|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-9|62|672|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-10|62|679|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-11|62|693|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-12|62|693|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-13|62|700|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-14|62|728|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-15|62|728|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-16|62|735|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-17|62|756|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-18|62|763|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-19|62|763|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-20|62|770|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-21|62|777|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-22|62|784|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-23|62|805|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-24|62|812|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-25|62|819|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-26|62|819|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-27|62|833|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-28|62|840|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-29|62|840|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-30|62|847|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-31|62|861|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-32|62|861|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-33|62|882|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-34|62|896|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-35|62|903|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-36|62|917|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-37|62|938|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-38|62|966|Other deterministic changes|Mammary gland|n/a|
11-1-62|XSdOv-Gy 0.1,ASXT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-62-39|62|1015|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-1|63|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-2|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-3|63|707|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-4|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-5|63|532|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-6|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-7|63|371|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-8|63|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-9|63|378|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-10|63|469|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-11|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-12|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-13|63|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-14|63|623|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-15|63|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-16|63|455|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-17|63|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-18|63|539|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-19|63|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-20|63|546|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-21|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-22|63|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-23|63|385|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-24|63|490|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-25|63|364|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-26|63|567|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-27|63|469|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-28|63|546|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-29|63|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-30|63|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-31|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-32|63|525|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-33|63|343|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-34|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-35|63|490|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-36|63|483|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-37|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-38|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-39|63|462|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|1| 56|X-rays whole body|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-40|63|441|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-1|63|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-2|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-3|63|707|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-4|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-5|63|532|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-6|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-7|63|371|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-8|63|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-9|63|378|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-10|63|469|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-11|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-12|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-13|63|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-14|63|623|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-15|63|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-16|63|455|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-17|63|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-18|63|539|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-19|63|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-20|63|546|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-21|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-22|63|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-23|63|385|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-24|63|490|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-25|63|364|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-26|63|567|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-27|63|469|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-28|63|546|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-29|63|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-30|63|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-31|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-32|63|525|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-33|63|343|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-34|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-35|63|490|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-36|63|483|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-37|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-38|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-39|63|462|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-40|63|441|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-1|63|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-2|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-3|63|707|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-4|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-5|63|532|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-6|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-7|63|371|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-8|63|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-9|63|378|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-10|63|469|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-11|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-12|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-13|63|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-14|63|623|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-15|63|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-16|63|455|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-17|63|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-18|63|539|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-19|63|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-20|63|546|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-21|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-22|63|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-23|63|385|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-24|63|490|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-25|63|364|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-26|63|567|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-27|63|469|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-28|63|546|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-29|63|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-30|63|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-31|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-32|63|525|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-33|63|343|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-34|63|504|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-35|63|490|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-36|63|483|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-37|63|574|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-38|63|434|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-39|63|462|Other deterministic changes|Mammary gland|n/a|
11-1-63|XSdOeOv-Gy 0.1,ASXT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-63-40|63|441|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-1|64|357|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-2|64|378|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-3|64|406|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-4|64|406|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-5|64|441|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-6|64|441|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-7|64|448|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-8|64|476|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-9|64|497|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-10|64|504|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-11|64|511|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-12|64|511|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-13|64|518|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-14|64|532|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-15|64|532|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-16|64|539|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-17|64|553|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-18|64|567|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-19|64|574|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-20|64|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-21|64|574|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-22|64|595|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-23|64|595|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-24|64|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-25|64|623|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-26|64|637|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-27|64|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-28|64|658|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-29|64|658|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-30|64|665|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-31|64|679|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-32|64|679|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-33|64|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-34|64|686|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-35|64|693|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-36|64|700|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-37|64|707|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-38|64|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-39|64|707|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-40|64|707|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-41|64|714|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-42|64|749|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-43|64|749|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-44|64|756|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-45|64|777|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-46|64|777|Other deterministic changes|Mammary gland|n/a|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-47|64|791|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-48|64|833|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-64|XSd-Gy 0.3,ASXT_116.JA5NIH ASXT_116.JA2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-64-49|64|840|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-1|65|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-2|65|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-3|65|427|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-4|65|441|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-5|65|518|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-6|65|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-7|65|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-8|65|406|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-9|65|385|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-10|65|567|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-11|65|497|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-12|65|497|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-13|65|497|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-14|65|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-15|65|427|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-16|65|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-17|65|630|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-18|65|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-19|65|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-20|65|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-21|65|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-22|65|525|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-23|65|406|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-24|65|504|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-25|65|525|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-26|65|490|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-27|65|427|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-28|65|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-29|65|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-30|65|420|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-31|65|301|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-32|65|322|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-33|65|420|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-34|65|483|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-35|65|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-36|65|371|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-37|65|490|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-38|65|385|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-39|65|357|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-1|65|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-2|65|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-3|65|427|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-4|65|441|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-5|65|518|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-6|65|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-7|65|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-8|65|406|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-9|65|385|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-10|65|567|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-11|65|497|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-12|65|497|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-13|65|497|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-14|65|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-15|65|427|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-16|65|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-17|65|630|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-18|65|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-19|65|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-20|65|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-21|65|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-22|65|525|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-23|65|406|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-24|65|504|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-25|65|525|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-26|65|490|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-27|65|427|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-28|65|378|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-29|65|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-30|65|420|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-31|65|301|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-32|65|322|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-33|65|420|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-34|65|483|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-35|65|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-36|65|371|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-37|65|490|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-38|65|385|Other deterministic changes|Mammary gland|n/a|
11-1-65|XSdOe-Gy 0.3,ASXT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-65-39|65|357|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-1|66|294|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-2|66|490|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-3|66|511|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-4|66|511|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-5|66|567|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-6|66|581|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-7|66|609|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-8|66|756|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-9|66|791|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-10|66|805|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-11|66|833|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-12|66|833|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-13|66|840|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-14|66|882|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-15|66|889|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-16|66|889|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-17|66|938|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-18|66|938|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-19|66|119|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-1|66|294|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-2|66|490|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-3|66|511|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-4|66|511|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-5|66|567|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-6|66|581|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-7|66|609|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-8|66|756|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-9|66|791|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-10|66|805|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-11|66|833|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-12|66|833|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-13|66|840|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-14|66|882|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-15|66|889|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-16|66|889|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-17|66|938|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-18|66|938|Other deterministic changes|Mammary gland|n/a|
11-1-66|XSdOv-Gy 0.3,ASXT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-66-19|66|119|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-1|67|434|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-2|67|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-3|67|483|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-4|67|560|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-5|67|427|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-6|67|462|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-7|67|609|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-8|67|308|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-9|67|588|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-10|67|553|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-11|67|511|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-12|67|483|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-13|67|455|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-14|67|672|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-15|67|378|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-16|67|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-17|67|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-18|67|567|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-19|67|476|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|1| 56|X-rays whole body|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-20|67|560|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-1|67|434|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-2|67|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-3|67|483|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-4|67|560|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-5|67|427|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-6|67|462|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-7|67|609|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-8|67|308|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-9|67|588|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-10|67|553|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-11|67|511|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-12|67|483|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-13|67|455|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-14|67|672|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-15|67|378|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-16|67|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-17|67|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-18|67|567|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-19|67|476|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-20|67|560|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-1|67|434|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-2|67|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-3|67|483|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-4|67|560|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-5|67|427|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-6|67|462|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-7|67|609|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-8|67|308|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-9|67|588|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-10|67|553|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-11|67|511|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-12|67|483|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-13|67|455|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-14|67|672|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-15|67|378|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-16|67|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-17|67|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-18|67|567|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-19|67|476|Other deterministic changes|Mammary gland|n/a|
11-1-67|XSdOeOv-Gy 0.3,ASXT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-67-20|67|560|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-1|68|189|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-2|68|406|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-3|68|504|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-4|68|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-5|68|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-6|68|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-7|68|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-8|68|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-9|68|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-10|68|686|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-11|68|693|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-12|68|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-13|68|728|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-14|68|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-15|68|770|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-16|68|770|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-17|68|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-18|68|854|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-19|68|882|Other deterministic changes|Mammary gland|n/a|
11-1-68|XSd-Gy 1,ASXT_116.OA3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-68-20|68|889|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-1|69|630|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-2|69|469|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-3|69|490|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-4|69|511|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-5|69|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-6|69|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-7|69|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-8|69|315|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-9|69|567|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-10|69|462|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-11|69|497|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-12|69|518|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-13|69|413|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-14|69|539|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-15|69|511|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-16|69|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-17|69|504|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-18|69|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-19|69|413|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-20|69|476|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-21|69|364|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-22|69|448|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-23|69|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-24|69|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-25|69|364|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-26|69|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-27|69|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-28|69|546|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-29|69|574|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-30|69|574|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-31|69|378|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-32|69|448|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-33|69|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-34|69|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-35|69|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-36|69|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-37|69|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-38|69|420|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-39|69|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-40|69|546|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-41|69|525|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-42|69|315|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-43|69|560|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-44|69|322|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-45|69|357|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-46|69|630|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-47|69|483|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-48|69|357|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-49|69|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-1|69|630|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-2|69|469|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-3|69|490|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-4|69|511|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-5|69|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-6|69|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-7|69|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-8|69|315|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-9|69|567|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-10|69|462|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-11|69|497|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-12|69|518|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-13|69|413|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-14|69|539|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-15|69|511|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-16|69|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-17|69|504|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-18|69|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-19|69|413|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-20|69|476|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-21|69|364|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-22|69|448|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-23|69|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-24|69|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-25|69|364|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-26|69|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-27|69|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-28|69|546|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-29|69|574|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-30|69|574|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-31|69|378|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-32|69|448|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-33|69|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-34|69|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-35|69|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-36|69|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-37|69|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-38|69|420|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-39|69|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-40|69|546|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-41|69|525|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-42|69|315|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-43|69|560|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-44|69|322|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-45|69|357|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-46|69|630|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-47|69|483|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-48|69|357|Other deterministic changes|Mammary gland|n/a|
11-1-69|XSdOe-Gy 1,ASXT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-69-49|69|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 268 - adenocarcinoma|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-1|70|385|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-2|70|392|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-3|70|602|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-4|70|651|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-5|70|672|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-6|70|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-7|70|686|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-8|70|784|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-9|70|819|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-10|70|840|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-11|70|854|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-12|70|861|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-13|70|861|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-14|70|931|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-15|70|931|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-16|70|952|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-17|70|959|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-18|70|959|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-19|70|994|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-1|70|385|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-2|70|392|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-3|70|602|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-4|70|651|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-5|70|672|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-6|70|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-7|70|686|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-8|70|784|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-9|70|819|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-10|70|840|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-11|70|854|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-12|70|861|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-13|70|861|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-14|70|931|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-15|70|931|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-16|70|952|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-17|70|959|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-18|70|959|Other deterministic changes|Mammary gland|n/a|
11-1-70|XSdOv-Gy 1,ASXT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-70-19|70|994|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-1|71|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-2|71|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-3|71|448|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-4|71|511|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-5|71|441|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-6|71|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-7|71|462|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-8|71|602|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-9|71|455|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-10|71|546|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-11|71|329|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-12|71|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-13|71|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-14|71|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-15|71|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-16|71|490|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-17|71|490|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-18|71|392|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-19|71|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-20|71|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-1|71|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-2|71|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-3|71|448|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-4|71|511|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-5|71|441|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-6|71|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-7|71|462|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-8|71|602|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-9|71|455|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-10|71|546|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-11|71|329|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-12|71|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-13|71|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-14|71|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-15|71|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-16|71|490|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-17|71|490|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-18|71|392|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-19|71|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-20|71|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-1|71|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-2|71|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-3|71|448|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-4|71|511|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-5|71|441|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-6|71|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-7|71|462|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-8|71|602|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-9|71|455|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-10|71|546|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-11|71|329|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-12|71|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-13|71|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-14|71|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-15|71|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-16|71|490|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-17|71|490|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-18|71|392|Other deterministic changes|Mammary gland|n/a|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-19|71|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-71|XSdOeOv-Gy 1,ASXT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-71-20|71|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-1|72|399|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-2|72|406|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-3|72|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-4|72|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-5|72|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-6|72|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-7|72|476|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-8|72|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-9|72|504|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-10|72|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-11|72|525|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-12|72|532|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-13|72|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-14|72|567|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-15|72|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-16|72|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-17|72|609|Other deterministic changes|Mammary gland|n/a|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-18|72|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-19|72|700|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-72|XSd-Gy 2,ASXT_116.QA4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-72-20|72|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-1|73|364|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-2|73|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 218 - neoplasm|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-3|73|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-4|73|378|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-5|73|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-6|73|343|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-7|73|462|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-8|73|476|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-9|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-10|73|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-11|73|406|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-12|73|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-13|73|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-14|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-15|73|231|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-16|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-17|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-18|73|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-1|73|364|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-2|73|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 218 - neoplasm|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-3|73|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-4|73|378|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-5|73|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-6|73|343|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-7|73|462|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-8|73|476|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-9|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-10|73|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-11|73|406|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-12|73|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-13|73|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-14|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-15|73|231|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-16|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-17|73|441|Other deterministic changes|Mammary gland|n/a|
11-1-73|XSdOe-Gy 2,ASXT_116.QB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-73-18|73|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-1|74|273|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-2|74|350|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-3|74|364|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-4|74|406|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-5|74|511|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-6|74|546|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-7|74|581|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-8|74|616|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-9|74|644|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-10|74|651|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-11|74|651|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-12|74|651|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-13|74|686|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-14|74|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-15|74|686|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-16|74|700|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-17|74|728|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-18|74|728|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-19|74|784|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-20|74|784|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-1|74|273|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-2|74|350|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-3|74|364|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-4|74|406|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-5|74|511|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-6|74|546|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-7|74|581|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-8|74|616|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-9|74|644|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-10|74|651|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-11|74|651|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-12|74|651|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-13|74|686|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-14|74|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-15|74|686|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-16|74|700|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-17|74|728|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-18|74|728|Other deterministic changes|Mammary gland|n/a|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-19|74|784|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-74|XSdOv-Gy 2,ASXT_116.QC4NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-74-20|74|784|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-1|75|406|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-2|75|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-3|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-4|75|343|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-5|75|343|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-6|75|371|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-7|75|392|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-8|75|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-9|75|518|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-10|75|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-11|75|462|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-12|75|427|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-13|75|483|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-14|75|294|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-15|75|329|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-16|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-17|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-18|75|448|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-1|75|406|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-2|75|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-3|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-4|75|343|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-5|75|343|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-6|75|371|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-7|75|392|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-8|75|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-9|75|518|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-10|75|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-11|75|462|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-12|75|427|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-13|75|483|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-14|75|294|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-15|75|329|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-16|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-17|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-18|75|448|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-1|75|406|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-2|75|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-3|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-4|75|343|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-5|75|343|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-6|75|371|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-7|75|392|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-8|75|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-9|75|518|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-10|75|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-11|75|462|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-12|75|427|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-13|75|483|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-14|75|294|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-15|75|329|Other deterministic changes|Mammary gland|n/a|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-16|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-17|75|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-75|XSdOeOv-Gy 2,ASXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-75-18|75|448|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-1|76|315|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-2|76|371|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-3|76|427|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-4|76|490|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-5|76|525|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-6|76|532|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-7|76|539|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-8|76|546|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-9|76|567|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-10|76|574|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-11|76|574|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-12|76|588|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-13|76|588|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-14|76|588|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-15|76|588|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-16|76|588|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-17|76|595|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-18|76|595|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-19|76|595|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-20|76|595|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-21|76|595|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-22|76|602|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-23|76|630|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-24|76|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-25|76|630|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-26|76|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-27|76|637|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-28|76|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-29|76|651|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-30|76|651|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-31|76|658|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-32|76|672|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-33|76|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-34|76|714|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-35|76|721|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-36|76|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-37|76|777|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-38|76|777|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-39|76|805|Other deterministic changes|Mammary gland|n/a|
11-1-76|N.5Sd-Gy 0.02,ASHT_116.AA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-76-40|76|819|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-1|77|441|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-2|77|399|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-3|77|441|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-4|77|364|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-5|77|350|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-6|77|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-7|77|462|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-8|77|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-9|77|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-10|77|616|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-11|77|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-12|77|343|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-13|77|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-14|77|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-15|77|581|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-16|77|504|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-17|77|469|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-18|77|504|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-19|77|329|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-20|77|609|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-21|77|455|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-22|77|420|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-23|77|357|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-24|77|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-25|77|364|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-26|77|385|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-27|77|490|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-28|77|511|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-29|77|497|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-30|77|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-31|77|385|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-32|77|560|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-33|77|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-34|77|497|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-35|77|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-36|77|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-37|77|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-38|77|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-39|77|322|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-40|77|574|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-1|77|441|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-2|77|399|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-3|77|441|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-4|77|364|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-5|77|350|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-6|77|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-7|77|462|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-8|77|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-9|77|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-10|77|616|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-11|77|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-12|77|343|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-13|77|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-14|77|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-15|77|581|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-16|77|504|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-17|77|469|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-18|77|504|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-19|77|329|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-20|77|609|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-21|77|455|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-22|77|420|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-23|77|357|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-24|77|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-25|77|364|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-26|77|385|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-27|77|490|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-28|77|511|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-29|77|497|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-30|77|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-31|77|385|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-32|77|560|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-33|77|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-34|77|497|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-35|77|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-36|77|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-37|77|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-38|77|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-39|77|322|Other deterministic changes|Mammary gland|n/a|
11-1-77|N.5SdOe-Gy 0.02,ASHT_116.AB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-77-40|77|574|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-1|78|329|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-2|78|357|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-3|78|399|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-4|78|406|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-5|78|420|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-6|78|420|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-7|78|483|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-8|78|497|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-9|78|497|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-10|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-11|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-12|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-13|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-14|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-15|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-16|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-17|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-18|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-19|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-20|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-21|78|525|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-22|78|539|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-23|78|546|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-24|78|553|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-25|78|553|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-26|78|553|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-27|78|560|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-28|78|560|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-29|78|567|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-30|78|567|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-31|78|567|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-32|78|574|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-33|78|581|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-34|78|581|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-35|78|609|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-36|78|609|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-37|78|623|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-38|78|630|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-39|78|777|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-1|78|329|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-2|78|357|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-3|78|399|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-4|78|406|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-5|78|420|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-6|78|420|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-7|78|483|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-8|78|497|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-9|78|497|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-10|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-11|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-12|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-13|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-14|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-15|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-16|78|511|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-17|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-18|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-19|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-20|78|518|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-21|78|525|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-22|78|539|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-23|78|546|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-24|78|553|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-25|78|553|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-26|78|553|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-27|78|560|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-28|78|560|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-29|78|567|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-30|78|567|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-31|78|567|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-32|78|574|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-33|78|581|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-34|78|581|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-35|78|609|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-36|78|609|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-37|78|623|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-38|78|630|Other deterministic changes|Mammary gland|n/a|
11-1-78|N.5SdOv-Gy 0.02,ASHT_116.AC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-78-39|78|777|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-1|79|462|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-2|79|399|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-3|79|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-4|79|441|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-5|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-6|79|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-7|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-8|79|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-9|79|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-10|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-11|79|525|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-12|79|462|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-13|79|441|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-14|79|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 218 - neoplasm|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-15|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-16|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-17|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-18|79|364|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-19|79|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-20|79|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-21|79|280|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-22|79|490|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-23|79|490|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-24|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-25|79|448|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-26|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-27|79|357|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-28|79|539|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-29|79|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-30|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-31|79|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-32|79|469|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-33|79|476|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-34|79|539|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-35|79|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-36|79|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-37|79|630|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-38|79|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-39|79|476|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-1|79|462|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-2|79|399|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-3|79|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-4|79|441|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-5|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-6|79|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-7|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-8|79|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-9|79|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-10|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-11|79|525|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-12|79|462|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-13|79|441|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-14|79|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 218 - neoplasm|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-15|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-16|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-17|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-18|79|364|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-19|79|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-20|79|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-21|79|280|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-22|79|490|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-23|79|490|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-24|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-25|79|448|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-26|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-27|79|357|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-28|79|539|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-29|79|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-30|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-31|79|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-32|79|469|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-33|79|476|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-34|79|539|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-35|79|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-36|79|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-37|79|630|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-38|79|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-39|79|476|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-1|79|462|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-2|79|399|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-3|79|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-4|79|441|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-5|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-6|79|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-7|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-8|79|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-9|79|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-10|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-11|79|525|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-12|79|462|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-13|79|441|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-14|79|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 218 - neoplasm|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-15|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-16|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-17|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-18|79|364|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-19|79|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-20|79|644|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-21|79|280|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-22|79|490|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-23|79|490|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-24|79|497|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-25|79|448|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-26|79|455|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-27|79|357|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-28|79|539|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-29|79|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-30|79|413|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-31|79|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-32|79|469|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-33|79|476|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-34|79|539|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-35|79|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-36|79|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-37|79|630|Other deterministic changes|Mammary gland|n/a|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-38|79|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-79|N.5SdOeOv-Gy 0.02,ASHT_116.AD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-79-39|79|476|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-1|80|343|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-2|80|385|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-3|80|399|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-4|80|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-5|80|427|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-6|80|441|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-7|80|462|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-8|80|469|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-9|80|476|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-10|80|490|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-11|80|497|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-12|80|504|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-13|80|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-14|80|511|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-15|80|518|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-16|80|525|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-17|80|525|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-18|80|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-19|80|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-20|80|532|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-21|80|539|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-22|80|539|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-23|80|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-24|80|581|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-25|80|581|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-26|80|595|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-27|80|595|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-28|80|595|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-29|80|602|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-30|80|602|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-31|80|602|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-32|80|602|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-33|80|602|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-34|80|609|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-35|80|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-36|80|623|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-37|80|623|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-38|80|637|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-39|80|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-40|80|665|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-41|80|672|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-42|80|679|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-43|80|693|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-44|80|700|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-45|80|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-46|80|735|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-47|80|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-48|80|735|Other deterministic changes|Mammary gland|n/a|
11-1-80|N.5Sd-Gy 0.08,ASHT_116.DA2NIH ASHT_116.DA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-80-49|80|777|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-1|81|483|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-2|81|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-3|81|427|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-4|81|406|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-5|81|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-6|81|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-7|81|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-8|81|329|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-9|81|315|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-10|81|511|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-11|81|448|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-12|81|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-13|81|252|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-14|81|294|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-15|81|378|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-16|81|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-17|81|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-18|81|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-19|81|427|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-20|81|84|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-1|81|483|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-2|81|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-3|81|427|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-4|81|406|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-5|81|441|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-6|81|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-7|81|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-8|81|329|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-9|81|315|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-10|81|511|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-11|81|448|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-12|81|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-13|81|252|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-14|81|294|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-15|81|378|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-16|81|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-17|81|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-18|81|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-19|81|427|Other deterministic changes|Mammary gland|n/a|
11-1-81|N.5SdOe-Gy 0.08,ASHT_116.DB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-81-20|81|84|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-1|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-2|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-3|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-4|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-5|82|399|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-6|82|434|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-7|82|490|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-8|82|497|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-9|82|511|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-10|82|525|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-11|82|532|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-12|82|532|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-13|82|539|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-14|82|539|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-15|82|567|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-16|82|581|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-17|82|595|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-18|82|609|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-19|82|770|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-20|82|945|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-1|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-2|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-3|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-4|82|385|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-5|82|399|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-6|82|434|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-7|82|490|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-8|82|497|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-9|82|511|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-10|82|525|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-11|82|532|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-12|82|532|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-13|82|539|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-14|82|539|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-15|82|567|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-16|82|581|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-17|82|595|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-18|82|609|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-19|82|770|Other deterministic changes|Mammary gland|n/a|
11-1-82|N.5SdOv-Gy 0.08,ASHT_116.DC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-82-20|82|945|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-1|83|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-2|83|462|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-3|83|245|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-4|83|378|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-5|83|420|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-6|83|490|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-7|83|434|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-8|83|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-9|83|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-10|83|546|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-11|83|364|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-12|83|539|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-13|83|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-14|83|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-15|83|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-16|83|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-17|83|448|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-18|83|322|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-19|83|308|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-20|83|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-1|83|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-2|83|462|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-3|83|245|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-4|83|378|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-5|83|420|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-6|83|490|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-7|83|434|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-8|83|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-9|83|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-10|83|546|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-11|83|364|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-12|83|539|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-13|83|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-14|83|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-15|83|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-16|83|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-17|83|448|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-18|83|322|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-19|83|308|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-20|83|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-1|83|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-2|83|462|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-3|83|245|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-4|83|378|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-5|83|420|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-6|83|490|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-7|83|434|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-8|83|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-9|83|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-10|83|546|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-11|83|364|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-12|83|539|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-13|83|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-14|83|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-15|83|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-16|83|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-17|83|448|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-18|83|322|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-19|83|308|Other deterministic changes|Mammary gland|n/a|
11-1-83|N.5SdOeOv-Gy 0.08,ASHT_116.DD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-83-20|83|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-1|84|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-2|84|343|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-3|84|350|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-4|84|399|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-5|84|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-6|84|448|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-7|84|483|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-8|84|483|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-9|84|483|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-10|84|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-11|84|525|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-12|84|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-13|84|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-14|84|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-15|84|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-16|84|574|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-17|84|574|Other deterministic changes|Mammary gland|n/a|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-18|84|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 218 - neoplasm|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-19|84|665|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-84|N.5Sd-Gy 0.32,ASHT_116.KA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-84-20|84|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 218 - neoplasm|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-1|85|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-2|85|315|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-3|85|560|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-4|85|392|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-5|85|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-6|85|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-7|85|371|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-8|85|420|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-9|85|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-10|85|315|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-11|85|336|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-12|85|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-13|85|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-14|85|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-15|85|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-16|85|427|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-17|85|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-18|85|420|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-19|85|427|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-20|85|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-1|85|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-2|85|315|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-3|85|560|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-4|85|392|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-5|85|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-6|85|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-7|85|371|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-8|85|420|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-9|85|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-10|85|315|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-11|85|336|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-12|85|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-13|85|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-14|85|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-15|85|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-16|85|427|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-17|85|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-18|85|420|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-19|85|427|Other deterministic changes|Mammary gland|n/a|
11-1-85|N.5SdOe-Gy 0.32,ASHT_116.KB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-85-20|85|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-1|86|273|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-2|86|329|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-3|86|357|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-4|86|364|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-5|86|406|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-6|86|420|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-7|86|462|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-8|86|462|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-9|86|469|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-10|86|511|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-11|86|518|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-12|86|518|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-13|86|539|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-14|86|546|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-15|86|546|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-16|86|567|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-17|86|567|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-18|86|609|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-19|86|616|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-20|86|616|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-1|86|273|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-2|86|329|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-3|86|357|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-4|86|364|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-5|86|406|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-6|86|420|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-7|86|462|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-8|86|462|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-9|86|469|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-10|86|511|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-11|86|518|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-12|86|518|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-13|86|539|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-14|86|546|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-15|86|546|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-16|86|567|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-17|86|567|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-18|86|609|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-19|86|616|Other deterministic changes|Mammary gland|n/a|
11-1-86|N.5SdOv-Gy 0.32,ASHT_116.KC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-86-20|86|616|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-1|87|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-2|87|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-3|87|301|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-4|87|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-5|87|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-6|87|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-7|87|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-8|87|343|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-9|87|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-10|87|504|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-11|87|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-12|87|518|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-13|87|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-14|87|476|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-15|87|343|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-16|87|399|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-17|87|406|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-18|87|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.32|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-19|87|371|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-1|87|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-2|87|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-3|87|301|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-4|87|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-5|87|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-6|87|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-7|87|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-8|87|343|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-9|87|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-10|87|504|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-11|87|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-12|87|518|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-13|87|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-14|87|476|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-15|87|343|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-16|87|399|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-17|87|406|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-18|87|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-19|87|371|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-1|87|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-2|87|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-3|87|301|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-4|87|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-5|87|357|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-6|87|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-7|87|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-8|87|343|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-9|87|336|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-10|87|504|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-11|87|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-12|87|518|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-13|87|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-14|87|476|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-15|87|343|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-16|87|399|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-17|87|406|Other deterministic changes|Mammary gland|n/a|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-18|87|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-87|N.5SdOeOv-Gy 0.32,ASHT_116.KD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-87-19|87|371|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-1|88|189|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-2|88|322|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-3|88|434|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-4|88|434|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-5|88|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-6|88|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-7|88|497|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-8|88|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-9|88|532|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-10|88|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-11|88|546|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-12|88|560|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-13|88|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-14|88|574|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-15|88|574|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-16|88|574|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-17|88|581|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-18|88|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-19|88|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-20|88|637|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-21|88|665|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-22|88|686|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-23|88|693|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-24|88|700|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-25|88|700|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-26|88|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-27|88|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-28|88|728|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-29|88|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-30|88|728|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-31|88|735|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-32|88|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-33|88|784|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-34|88|784|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-35|88|791|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-36|88|798|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-37|88|826|Other deterministic changes|Mammary gland|n/a|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-38|88|847|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-39|88|875|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-88|N4Sd-Gy 0.04,ASIT_116.BA1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-88-40|88|889|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-1|89|427|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-2|89|364|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-3|89|490|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-4|89|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-5|89|574|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-6|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-7|89|511|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-8|89|455|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-9|89|448|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-10|89|476|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-11|89|385|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-12|89|364|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-13|89|434|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-14|89|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-15|89|448|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-16|89|448|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-17|89|371|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-18|89|245|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-19|89|434|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-20|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-21|89|371|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-22|89|406|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-23|89|518|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-24|89|441|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-25|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-26|89|322|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-27|89|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-28|89|511|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-29|89|371|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-30|89|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-31|89|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  5,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-32|89|483|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-33|89|392|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-34|89|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-35|89|462|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-36|89|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  1,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-37|89|392|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-38|89|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-39|89|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-40|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-1|89|427|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-2|89|364|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-3|89|490|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-4|89|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-5|89|574|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-6|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-7|89|511|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-8|89|455|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-9|89|448|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-10|89|476|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-11|89|385|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-12|89|364|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-13|89|434|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-14|89|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-15|89|448|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-16|89|448|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-17|89|371|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-18|89|245|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-19|89|434|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-20|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-21|89|371|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-22|89|406|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-23|89|518|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-24|89|441|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-25|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-26|89|322|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-27|89|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-28|89|511|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-29|89|371|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-30|89|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-31|89|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  5,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-32|89|483|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-33|89|392|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-34|89|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-35|89|462|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-36|89|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  1,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-37|89|392|Other deterministic changes|Mammary gland|n/a|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-38|89|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-39|89|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-89|N4SdOe-Gy 0.04,ASIT_116.BB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-89-40|89|532|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-1|90|469|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-2|90|497|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-3|90|497|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-4|90|511|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-5|90|574|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-6|90|609|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-7|90|609|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-8|90|609|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-9|90|623|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-10|90|637|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-11|90|651|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-12|90|651|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-13|90|658|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-14|90|672|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-15|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-16|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-17|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-18|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-19|90|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 218 - neoplasm|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-20|90|693|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-21|90|693|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-22|90|693|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-23|90|700|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-24|90|700|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-25|90|700|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-26|90|707|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-27|90|714|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-28|90|714|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-29|90|721|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-30|90|742|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-31|90|756|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-32|90|763|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-33|90|763|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-34|90|791|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-35|90|791|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-36|90|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-37|90|868|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-38|90|931|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-39|90|931|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-40|90|161|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-1|90|469|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-2|90|497|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-3|90|497|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-4|90|511|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-5|90|574|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-6|90|609|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-7|90|609|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-8|90|609|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-9|90|623|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-10|90|637|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-11|90|651|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-12|90|651|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-13|90|658|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-14|90|672|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-15|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-16|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-17|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-18|90|679|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-19|90|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 218 - neoplasm|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-20|90|693|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-21|90|693|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-22|90|693|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-23|90|700|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-24|90|700|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-25|90|700|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-26|90|707|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-27|90|714|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-28|90|714|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-29|90|721|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-30|90|742|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-31|90|756|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-32|90|763|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-33|90|763|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-34|90|791|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-35|90|791|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-36|90|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-37|90|868|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-38|90|931|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-39|90|931|Other deterministic changes|Mammary gland|n/a|
11-1-90|N4SdOv-Gy 0.04,ASIT_116.BC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-90-40|90|161|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-1|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-2|91|469|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-3|91|462|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-4|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-5|91|448|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-6|91|462|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-7|91|574|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-8|91|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-9|91|420|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-10|91|595|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-11|91|504|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-12|91|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-13|91|280|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-14|91|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-15|91|441|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-16|91|441|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-17|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-18|91|658|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-19|91|525|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-20|91|504|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-21|91|525|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-22|91|602|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-23|91|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-24|91|497|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-25|91|581|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-26|91|581|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-27|91|630|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-28|91|567|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-29|91|553|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-30|91|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-31|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-32|91|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-33|91|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-34|91|630|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-35|91|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-36|91|455|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-37|91|280|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-38|91|455|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-39|91|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|1| 56|neutrons 1-10 MeV|0.04|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-40|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-1|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-2|91|469|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-3|91|462|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-4|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-5|91|448|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-6|91|462|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-7|91|574|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-8|91|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-9|91|420|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-10|91|595|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-11|91|504|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-12|91|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-13|91|280|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-14|91|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-15|91|441|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-16|91|441|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-17|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-18|91|658|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-19|91|525|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-20|91|504|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-21|91|525|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-22|91|602|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-23|91|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-24|91|497|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-25|91|581|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-26|91|581|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-27|91|630|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-28|91|567|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-29|91|553|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-30|91|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-31|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-32|91|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-33|91|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-34|91|630|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-35|91|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-36|91|455|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-37|91|280|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-38|91|455|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-39|91|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-40|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-1|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-2|91|469|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-3|91|462|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-4|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-5|91|448|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-6|91|462|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-7|91|574|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-8|91|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-9|91|420|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-10|91|595|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-11|91|504|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-12|91|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-13|91|280|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-14|91|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-15|91|441|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-16|91|441|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-17|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-18|91|658|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-19|91|525|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-20|91|504|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-21|91|525|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-22|91|602|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-23|91|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-24|91|497|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-25|91|581|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-26|91|581|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-27|91|630|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-28|91|567|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-29|91|553|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-30|91|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-31|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-32|91|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-33|91|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-34|91|630|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-35|91|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-36|91|455|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-37|91|280|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-38|91|455|Other deterministic changes|Mammary gland|n/a|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-39|91|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-91|N4SdOeOv-Gy 0.04,ASIT_116.BD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-91-40|91|637|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-1|92|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-2|92|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-3|92|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-4|92|406|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-5|92|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-6|92|392|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-7|92|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-8|92|476|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-9|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-10|92|441|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-11|92|504|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-12|92|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 218 - neoplasm|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-13|92|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-14|92|511|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-15|92|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-16|92|399|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-17|92|483|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-18|92|427|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-19|92|546|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-20|92|462|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-21|92|210|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-22|92|490|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-23|92|385|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-24|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-25|92|406|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-26|92|441|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-27|92|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-28|92|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-29|92|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-30|92|462|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-31|92|511|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-32|92|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-33|92|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-34|92|392|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-35|92|595|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-36|92|539|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-37|92|420|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-38|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-39|92|420|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|1| 56|neutrons 1-10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-40|92|140|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-1|92|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-2|92|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-3|92|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-4|92|406|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-5|92|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-6|92|392|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-7|92|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-8|92|476|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-9|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-10|92|441|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-11|92|504|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-12|92|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 218 - neoplasm|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-13|92|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-14|92|511|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-15|92|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-16|92|399|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-17|92|483|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-18|92|427|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-19|92|546|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-20|92|462|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-21|92|210|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-22|92|490|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-23|92|385|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-24|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-25|92|406|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-26|92|441|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-27|92|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-28|92|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-29|92|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-30|92|462|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-31|92|511|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-32|92|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-33|92|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-34|92|392|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-35|92|595|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-36|92|539|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-37|92|420|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-38|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-39|92|420|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-40|92|140|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-1|92|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-2|92|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-3|92|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-4|92|406|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-5|92|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-6|92|392|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-7|92|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-8|92|476|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-9|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-10|92|441|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-11|92|504|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-12|92|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 218 - neoplasm|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-13|92|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-14|92|511|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-15|92|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-16|92|399|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-17|92|483|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-18|92|427|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-19|92|546|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-20|92|462|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-21|92|210|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-22|92|490|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-23|92|385|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-24|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-25|92|406|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-26|92|441|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-27|92|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-28|92|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-29|92|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-30|92|462|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-31|92|511|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-32|92|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-33|92|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-34|92|392|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-35|92|595|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-36|92|539|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-37|92|420|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-38|92|469|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-39|92|420|Other deterministic changes|Mammary gland|n/a|
11-1-92|N4SdOeOv-Gy 0.05,ASIT_116.CD5NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-92-40|92|140|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-1|93|357|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-2|93|399|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-3|93|413|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-4|93|434|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-5|93|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-6|93|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-7|93|455|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-8|93|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-9|93|490|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-10|93|497|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-11|93|504|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-12|93|504|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-13|93|511|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-14|93|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-15|93|518|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-16|93|518|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-17|93|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-18|93|539|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-19|93|539|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-20|93|539|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-21|93|539|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-22|93|553|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-23|93|560|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-24|93|560|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-25|93|567|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-26|93|567|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-27|93|581|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-28|93|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-29|93|588|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-30|93|588|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-31|93|588|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-32|93|602|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-33|93|602|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-34|93|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-35|93|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-36|93|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-37|93|623|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-38|93|637|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-39|93|637|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-40|93|644|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-41|93|665|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-42|93|665|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-43|93|665|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-44|93|672|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-45|93|686|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-46|93|693|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-47|93|707|Other deterministic changes|Mammary gland|n/a|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-48|93|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-49|93|805|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-93|N4Sd-Gy 0.12,ASIT_116.FA2NIH ASIT_116.FA5NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-93-50|93|882|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-1|94|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-2|94|280|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-3|94|462|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-4|94|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-5|94|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-6|94|427|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-7|94|448|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-8|94|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-9|94|399|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-10|94|546|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-11|94|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-12|94|539|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-13|94|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-14|94|574|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-15|94|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-16|94|518|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-17|94|532|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-18|94|525|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-19|94|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-20|94|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-1|94|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 1 Size  0,MPATH: 268 - adenocarcinoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-2|94|280|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-3|94|462|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-4|94|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-5|94|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-6|94|427|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-7|94|448|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-8|94|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-9|94|399|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-10|94|546|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-11|94|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-12|94|539|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-13|94|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-14|94|574|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-15|94|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-16|94|518|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-17|94|532|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-18|94|525|Other deterministic changes|Mammary gland|n/a|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-19|94|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-94|N4SdOe-Gy 0.12,ASIT_116.FB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-94-20|94|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-1|95|364|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-2|95|476|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-3|95|518|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-4|95|539|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-5|95|546|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-6|95|553|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-7|95|574|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-8|95|595|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-9|95|637|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-10|95|637|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-11|95|637|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-12|95|658|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-13|95|665|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-14|95|665|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-15|95|714|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-16|95|721|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-17|95|798|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-18|95|973|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-1|95|364|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-2|95|476|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-3|95|518|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-4|95|539|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-5|95|546|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-6|95|553|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-7|95|574|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-8|95|595|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-9|95|637|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-10|95|637|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-11|95|637|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-12|95|658|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-13|95|665|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-14|95|665|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-15|95|714|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-16|95|721|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-17|95|798|Other deterministic changes|Mammary gland|n/a|
11-1-95|N4SdOv-Gy 0.12,ASIT_116.FC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-95-18|95|973|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-1|96|490|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-2|96|595|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-3|96|441|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-4|96|357|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-5|96|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-6|96|455|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-7|96|301|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-8|96|378|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-9|96|497|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-10|96|357|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-11|96|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-12|96|497|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-13|96|336|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-14|96|392|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-15|96|476|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-16|96|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-17|96|469|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-18|96|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-19|96|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|1| 56|neutrons 1-10 MeV|0.12|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-20|96|623|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-1|96|490|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-2|96|595|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-3|96|441|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-4|96|357|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-5|96|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-6|96|455|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-7|96|301|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-8|96|378|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-9|96|497|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-10|96|357|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-11|96|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-12|96|497|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-13|96|336|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-14|96|392|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-15|96|476|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-16|96|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-17|96|469|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-18|96|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-19|96|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-20|96|623|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-1|96|490|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-2|96|595|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-3|96|441|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-4|96|357|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-5|96|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-6|96|455|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-7|96|301|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-8|96|378|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-9|96|497|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-10|96|357|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-11|96|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-12|96|497|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-13|96|336|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-14|96|392|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-15|96|476|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-16|96|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 268 - adenocarcinoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-17|96|469|Other deterministic changes|Mammary gland|n/a|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-18|96|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-19|96|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-96|N4SdOeOv-Gy 0.12,ASIT_116.FD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-96-20|96|623|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-1|97|280|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-2|97|315|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-3|97|364|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-4|97|434|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-5|97|448|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-6|97|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-7|97|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-8|97|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-9|97|525|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-10|97|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-11|97|539|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-12|97|553|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-13|97|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-14|97|567|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-15|97|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-16|97|602|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-17|97|602|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-18|97|630|Other deterministic changes|Mammary gland|n/a|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-19|97|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-97|N4Sd-Gy 0.4,ASIT_116.LA3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-97-20|97|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-1|98|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-2|98|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-3|98|406|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-4|98|497|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-5|98|406|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-6|98|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-7|98|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-8|98|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-9|98|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-10|98|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-11|98|462|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-12|98|413|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-13|98|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-14|98|357|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-15|98|378|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-16|98|539|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-17|98|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-18|98|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-19|98|399|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-20|98|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-1|98|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-2|98|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-3|98|406|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-4|98|497|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-5|98|406|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-6|98|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-7|98|406|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-8|98|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-9|98|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-10|98|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-11|98|462|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-12|98|413|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-13|98|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-14|98|357|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-15|98|378|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-16|98|539|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-17|98|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-18|98|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-19|98|399|Other deterministic changes|Mammary gland|n/a|
11-1-98|N4SdOe-Gy 0.4,ASIT_116.LB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-98-20|98|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-1|99|511|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-2|99|525|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-3|99|602|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-4|99|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-5|99|602|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-6|99|616|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-7|99|623|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-8|99|665|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-9|99|672|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-10|99|672|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-11|99|679|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-12|99|686|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-13|99|686|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-14|99|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-15|99|721|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-16|99|721|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-17|99|721|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-18|99|833|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-19|99|875|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-20|99|875|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-1|99|511|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-2|99|525|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-3|99|602|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-4|99|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-5|99|602|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-6|99|616|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-7|99|623|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-8|99|665|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-9|99|672|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-10|99|672|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-11|99|679|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-12|99|686|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-13|99|686|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-14|99|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-15|99|721|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-16|99|721|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-17|99|721|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-18|99|833|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-19|99|875|Other deterministic changes|Mammary gland|n/a|
11-1-99|N4SdOv-Gy 0.4,ASIT_116.LC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-99-20|99|875|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-1|100|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-2|100|532|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-3|100|392|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-4|100|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-5|100|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-6|100|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-7|100|448|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-8|100|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-9|100|287|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-10|100|343|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-11|100|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-12|100|371|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-13|100|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-14|100|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-15|100|462|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-16|100|427|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-17|100|392|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-18|100|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-19|100|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|1| 56|neutrons 1-10 MeV|0.4|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-20|100|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-1|100|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-2|100|532|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-3|100|392|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-4|100|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-5|100|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-6|100|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-7|100|448|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-8|100|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-9|100|287|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-10|100|343|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-11|100|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-12|100|371|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-13|100|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-14|100|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-15|100|462|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-16|100|427|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-17|100|392|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-18|100|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-19|100|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-20|100|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-1|100|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-2|100|532|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-3|100|392|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-4|100|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-5|100|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-6|100|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-7|100|448|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-8|100|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-9|100|287|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-10|100|343|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-11|100|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-12|100|371|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-13|100|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-14|100|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-15|100|462|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-16|100|427|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-17|100|392|Other deterministic changes|Mammary gland|n/a|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-18|100|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-19|100|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-100|N4SdOeOv-Gy 0.4,ASIT_116.LD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-100-20|100|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-1|101|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-2|101|385|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-3|101|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-4|101|385|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-5|101|378|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-6|101|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-7|101|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-8|101|336|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-9|101|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-10|101|308|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-11|101|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-12|101|476|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-13|101|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-14|101|357|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-15|101|322|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-16|101|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-17|101|315|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-18|101|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|1| 56|neutrons 1-10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-19|101|336|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-1|101|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-2|101|385|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-3|101|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-4|101|385|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-5|101|378|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-6|101|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-7|101|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-8|101|336|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-9|101|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-10|101|308|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-11|101|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-12|101|476|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-13|101|392|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-14|101|357|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-15|101|322|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-16|101|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-17|101|315|Other deterministic changes|Mammary gland|n/a|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-18|101|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-101|N4SdOe-Gy 0.5,ASIT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-101-19|101|336|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-1|102|462|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-2|102|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-3|102|546|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-4|102|567|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-5|102|567|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-6|102|574|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-7|102|609|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-8|102|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-9|102|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-10|102|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-11|102|644|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-12|102|644|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-13|102|658|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-14|102|672|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-15|102|672|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-16|102|672|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-17|102|679|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-18|102|679|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-19|102|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-20|102|686|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-21|102|693|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-22|102|700|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-23|102|707|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-24|102|707|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-25|102|714|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-26|102|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-27|102|742|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-28|102|742|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-29|102|742|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-30|102|756|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-31|102|777|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-32|102|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 218 - neoplasm|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-33|102|798|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-34|102|812|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-35|102|819|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-36|102|833|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-37|102|833|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-38|102|847|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-39|102|847|Other deterministic changes|Mammary gland|n/a|
11-1-102|N15Sd-Gy 0.05,ASJT_116.CA1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-102-40|102|903|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-1|103|294|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-2|103|504|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-3|103|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 218 - neoplasm|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-4|103|560|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-5|103|567|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-6|103|378|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-7|103|413|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-8|103|490|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-9|103|511|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-10|103|560|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-11|103|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-12|103|567|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-13|103|455|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-14|103|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-15|103|448|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-16|103|616|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-17|103|469|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-18|103|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-19|103|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-20|103|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-21|103|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-22|103|448|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-23|103|539|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-24|103|511|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-25|103|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-26|103|539|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-27|103|539|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-28|103|329|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-29|103|546|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-30|103|469|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-31|103|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-32|103|623|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-33|103|623|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-34|103|420|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-35|103|532|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-36|103|357|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-37|103|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-38|103|546|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-39|103|441|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-40|103|385|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-1|103|294|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-2|103|504|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-3|103|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 218 - neoplasm|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-4|103|560|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-5|103|567|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-6|103|378|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-7|103|413|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-8|103|490|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-9|103|511|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-10|103|560|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-11|103|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-12|103|567|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-13|103|455|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-14|103|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-15|103|448|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-16|103|616|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-17|103|469|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-18|103|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-19|103|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-20|103|588|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-21|103|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-22|103|448|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-23|103|539|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-24|103|511|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-25|103|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-26|103|539|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-27|103|539|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-28|103|329|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-29|103|546|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-30|103|469|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-31|103|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-32|103|623|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-33|103|623|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-34|103|420|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-35|103|532|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-36|103|357|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-37|103|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-38|103|546|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-39|103|441|Other deterministic changes|Mammary gland|n/a|
11-1-103|N15SdOe-Gy 0.05,ASJT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-103-40|103|385|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-1|104|217|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-2|104|224|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-3|104|420|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-4|104|420|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-5|104|434|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-6|104|434|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-7|104|441|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-8|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-9|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-10|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-11|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-12|104|490|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-13|104|497|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-14|104|511|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-15|104|518|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-16|104|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-17|104|525|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-18|104|539|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-19|104|539|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-20|104|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-21|104|553|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-22|104|553|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-23|104|553|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-24|104|560|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-25|104|560|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-26|104|567|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-27|104|574|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-28|104|595|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-29|104|595|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-30|104|609|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-31|104|609|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-32|104|616|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-33|104|616|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-34|104|623|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-35|104|623|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-36|104|630|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-37|104|630|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-38|104|630|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-39|104|644|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-40|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-41|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-42|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-43|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-44|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-45|104|665|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-46|104|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-47|104|679|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-48|104|686|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-49|104|693|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-50|104|693|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-51|104|707|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-52|104|714|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-53|104|728|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-54|104|728|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-55|104|735|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-56|104|735|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-57|104|735|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-58|104|742|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-59|104|749|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-60|104|770|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-61|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-62|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-63|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-64|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-65|104|798|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-66|104|805|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-67|104|819|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-68|104|833|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-69|104|840|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-70|104|840|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-71|104|861|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-72|104|861|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-73|104|868|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-74|104|868|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-75|104|868|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-76|104|903|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-77|104|917|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-78|104|91|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-1|104|217|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-2|104|224|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-3|104|420|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-4|104|420|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-5|104|434|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-6|104|434|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-7|104|441|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-8|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-9|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-10|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-11|104|476|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-12|104|490|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-13|104|497|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-14|104|511|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-15|104|518|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-16|104|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-17|104|525|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-18|104|539|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-19|104|539|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-20|104|553|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-21|104|553|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-22|104|553|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-23|104|553|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-24|104|560|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-25|104|560|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-26|104|567|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-27|104|574|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-28|104|595|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-29|104|595|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-30|104|609|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-31|104|609|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-32|104|616|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-33|104|616|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-34|104|623|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-35|104|623|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-36|104|630|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-37|104|630|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-38|104|630|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-39|104|644|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-40|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-41|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-42|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-43|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-44|104|651|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-45|104|665|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-46|104|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-47|104|679|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-48|104|686|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-49|104|693|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-50|104|693|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-51|104|707|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-52|104|714|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-53|104|728|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-54|104|728|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-55|104|735|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-56|104|735|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-57|104|735|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-58|104|742|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-59|104|749|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-60|104|770|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-61|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-62|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-63|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-64|104|784|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-65|104|798|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-66|104|805|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-67|104|819|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-68|104|833|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-69|104|840|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-70|104|840|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-71|104|861|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-72|104|861|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-73|104|868|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-74|104|868|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-75|104|868|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-76|104|903|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-77|104|917|Other deterministic changes|Mammary gland|n/a|
11-1-104|N15SdOv-Gy 0.05,ASJT_116.CC5NIH ASJT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|78 (78 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-104-78|104|91|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-1|105|315|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-2|105|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-3|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-4|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-5|105|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-6|105|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-7|105|427|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-8|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-9|105|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-10|105|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-11|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-12|105|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-13|105|476|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-14|105|385|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-15|105|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-16|105|441|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-17|105|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-18|105|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-19|105|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-20|105|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-21|105|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-22|105|525|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-23|105|406|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-24|105|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-25|105|406|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-26|105|308|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-27|105|462|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-28|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-29|105|518|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-30|105|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-31|105|539|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-32|105|469|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-33|105|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-34|105|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-35|105|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-36|105|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-37|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-38|105|357|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|1| 56|neutrons>10 MeV|0.05|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-39|105|462|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-1|105|315|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-2|105|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-3|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-4|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-5|105|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-6|105|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-7|105|427|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-8|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-9|105|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-10|105|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-11|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-12|105|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-13|105|476|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-14|105|385|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-15|105|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-16|105|441|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-17|105|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-18|105|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-19|105|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-20|105|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-21|105|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-22|105|525|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-23|105|406|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-24|105|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-25|105|406|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-26|105|308|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-27|105|462|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-28|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-29|105|518|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-30|105|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-31|105|539|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-32|105|469|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-33|105|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-34|105|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-35|105|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-36|105|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-37|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-38|105|357|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-39|105|462|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-1|105|315|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-2|105|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-3|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-4|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-5|105|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-6|105|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-7|105|427|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-8|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-9|105|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-10|105|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-11|105|448|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-12|105|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-13|105|476|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-14|105|385|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-15|105|399|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-16|105|441|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-17|105|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-18|105|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-19|105|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-20|105|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-21|105|483|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-22|105|525|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-23|105|406|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-24|105|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-25|105|406|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-26|105|308|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-27|105|462|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-28|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-29|105|518|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-30|105|595|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-31|105|539|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-32|105|469|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-33|105|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-34|105|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-35|105|581|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-36|105|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-37|105|504|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-38|105|357|Other deterministic changes|Mammary gland|n/a|
11-1-105|N15SdOeOv-Gy 0.05,ASJT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-105-39|105|462|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-1|106|259|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-2|106|392|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-3|106|392|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-4|106|399|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-5|106|434|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-6|106|448|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-7|106|476|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-8|106|476|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-9|106|483|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-10|106|490|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-11|106|490|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-12|106|490|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-13|106|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-14|106|511|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-15|106|518|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-16|106|518|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-17|106|518|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-18|106|532|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-19|106|532|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-20|106|553|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-21|106|574|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-22|106|574|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-23|106|574|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-24|106|581|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-25|106|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-26|106|595|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-27|106|616|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-28|106|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-29|106|616|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-30|106|623|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-31|106|623|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-32|106|630|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-33|106|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-34|106|679|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-35|106|679|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-36|106|686|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-37|106|686|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-38|106|700|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-39|106|707|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-40|106|728|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-41|106|742|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-42|106|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-43|106|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-44|106|763|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-45|106|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-46|106|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-47|106|805|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-48|106|812|Other deterministic changes|Mammary gland|n/a|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-49|106|826|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-106|N15Sd-Gy 0.15,ASJT_116.GA2NIH ASJT_116.GA5NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-106-50|106|896|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-1|107|448|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-2|107|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-3|107|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-4|107|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-5|107|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-6|107|504|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-7|107|504|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-8|107|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-9|107|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-10|107|371|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-11|107|406|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-12|107|511|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-13|107|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-14|107|371|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-15|107|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-16|107|420|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-17|107|427|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-18|107|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-19|107|497|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-20|107|266|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-1|107|448|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-2|107|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-3|107|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-4|107|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-5|107|525|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-6|107|504|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-7|107|504|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-8|107|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-9|107|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-10|107|371|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-11|107|406|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-12|107|511|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-13|107|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  9,MPATH: 266 - fibroadenoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-14|107|371|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-15|107|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-16|107|420|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-17|107|427|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-18|107|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-19|107|497|Other deterministic changes|Mammary gland|n/a|
11-1-107|N15SdOe-Gy 0.15,ASJT_116.GB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-107-20|107|266|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-1|108|350|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-2|108|448|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-3|108|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-4|108|616|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-5|108|693|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-6|108|756|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-7|108|770|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-8|108|784|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-9|108|882|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-10|108|882|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-11|108|903|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-12|108|924|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-13|108|931|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-14|108|973|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-15|108|1001|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-16|108|1001|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-17|108|1015|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-18|108|1015|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-19|108|1050|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-20|108|1071|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-1|108|350|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-2|108|448|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-3|108|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-4|108|616|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-5|108|693|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-6|108|756|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-7|108|770|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-8|108|784|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-9|108|882|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-10|108|882|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-11|108|903|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-12|108|924|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-13|108|931|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-14|108|973|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-15|108|1001|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-16|108|1001|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-17|108|1015|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-18|108|1015|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-19|108|1050|Other deterministic changes|Mammary gland|n/a|
11-1-108|N15SdOv-Gy 0.15,ASJT_116.GC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-108-20|108|1071|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-1|109|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-2|109|392|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-3|109|427|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-4|109|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-5|109|336|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-6|109|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-7|109|378|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-8|109|378|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-9|109|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-10|109|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-11|109|497|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-12|109|525|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-13|109|525|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-14|109|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-15|109|343|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-16|109|413|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-17|109|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-18|109|322|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-19|109|511|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-1|109|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-2|109|392|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-3|109|427|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-4|109|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-5|109|336|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-6|109|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-7|109|378|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-8|109|378|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-9|109|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-10|109|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-11|109|497|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-12|109|525|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-13|109|525|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-14|109|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-15|109|343|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-16|109|413|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-17|109|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-18|109|322|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-19|109|511|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-1|109|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-2|109|392|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-3|109|427|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-4|109|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-5|109|336|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-6|109|427|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-7|109|378|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-8|109|378|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-9|109|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-10|109|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-11|109|497|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-12|109|525|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-13|109|525|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-14|109|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-15|109|343|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-16|109|413|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-17|109|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-18|109|322|Other deterministic changes|Mammary gland|n/a|
11-1-109|N15SdOeOv-Gy 0.15,ASJT_116.GD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-109-19|109|511|Other deterministic changes|Mammary gland|n/a|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-1|110|420|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-2|110|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-3|110|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-4|110|448|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-5|110|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-6|110|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-7|110|553|Other deterministic changes|Mammary gland|n/a|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-8|110|560|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-9|110|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-10|110|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-11|110|581|Other deterministic changes|Mammary gland|n/a|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-12|110|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-13|110|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-14|110|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-15|110|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-16|110|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-17|110|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-18|110|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-19|110|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-110|N15Sd-Gy 0.5,ASJT_116.MA3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-110-20|110|728|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-1|111|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-2|111|350|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-3|111|329|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-4|111|343|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-5|111|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-6|111|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-7|111|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-8|111|385|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-9|111|308|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-10|111|378|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-11|111|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-12|111|329|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-13|111|273|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-14|111|406|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-15|111|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-16|111|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-17|111|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-18|111|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-19|111|462|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-20|111|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-1|111|434|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-2|111|350|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-3|111|329|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-4|111|343|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-5|111|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-6|111|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-7|111|371|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-8|111|385|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-9|111|308|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-10|111|378|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-11|111|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-12|111|329|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-13|111|273|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-14|111|406|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-15|111|448|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-16|111|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-17|111|518|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  4,MPATH: 268 - adenocarcinoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-18|111|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-19|111|462|Other deterministic changes|Mammary gland|n/a|
11-1-111|N15SdOe-Gy 0.5,ASJT_116.MB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-111-20|111|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-1|112|245|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-2|112|546|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-3|112|616|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-4|112|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-5|112|679|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-6|112|700|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-7|112|714|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-8|112|749|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-9|112|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-10|112|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-11|112|812|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-12|112|812|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-13|112|833|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-14|112|896|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-15|112|917|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-16|112|917|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-17|112|931|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-18|112|938|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-1|112|245|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-2|112|546|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-3|112|616|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-4|112|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-5|112|679|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-6|112|700|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-7|112|714|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-8|112|749|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-9|112|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-10|112|791|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 218 - neoplasm|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-11|112|812|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-12|112|812|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-13|112|833|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-14|112|896|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-15|112|917|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-16|112|917|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-17|112|931|Other deterministic changes|Mammary gland|n/a|
11-1-112|N15SdOv-Gy 0.5,ASJT_116.MC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-112-18|112|938|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-1|113|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-2|113|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-3|113|413|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-4|113|427|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-5|113|441|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-6|113|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-7|113|490|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-8|113|462|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-9|113|385|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-10|113|455|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-11|113|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-12|113|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-13|113|392|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-14|113|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-15|113|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-16|113|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-17|113|385|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-18|113|364|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-19|113|357|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-1|113|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-2|113|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-3|113|413|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-4|113|427|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-5|113|441|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-6|113|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-7|113|490|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-8|113|462|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-9|113|385|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-10|113|455|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-11|113|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-12|113|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-13|113|392|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-14|113|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-15|113|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-16|113|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-17|113|385|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-18|113|364|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-19|113|357|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-1|113|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-2|113|385|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-3|113|413|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-4|113|427|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-5|113|441|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-6|113|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  3,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-7|113|490|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-8|113|462|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-9|113|385|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-10|113|455|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-11|113|476|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 268 - adenocarcinoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-12|113|350|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-13|113|392|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-14|113|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-15|113|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-16|113|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-17|113|385|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-18|113|364|Other deterministic changes|Mammary gland|n/a|
11-1-113|N15SdOeOv-Gy 0.5,ASJT_116.MD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat, Sprague Dawley (SD/RIJ)|Female|Young Adult|visible/palpable tumors|11-1-113-19|113|357|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-1|114|259|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-2|114|266|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-3|114|266|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-4|114|280|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-5|114|280|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-6|114|280|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-7|114|301|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-8|114|308|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-9|114|315|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-10|114|315|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-11|114|343|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-12|114|343|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-13|114|343|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-14|114|350|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-15|114|350|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-16|114|350|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-17|114|350|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-18|114|364|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-19|114|364|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-20|114|364|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-21|114|364|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-22|114|385|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-23|114|385|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-24|114|385|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-25|114|385|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-26|114|385|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-27|114|385|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-28|114|392|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-29|114|392|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-30|114|413|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-31|114|427|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-32|114|427|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-33|114|427|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-34|114|441|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-35|114|441|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-36|114|448|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-37|114|448|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-38|114|448|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-39|114|448|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-40|114|455|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-41|114|462|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-42|114|469|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-43|114|469|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-44|114|469|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-45|114|469|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-46|114|476|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-47|114|483|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-48|114|483|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-49|114|483|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-50|114|490|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-51|114|497|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-52|114|504|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-53|114|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 266 - fibroadenoma|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-54|114|518|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-55|114|525|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-56|114|525|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-57|114|539|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-58|114|539|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-59|114|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-60|114|567|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-61|114|567|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-62|114|574|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-63|114|616|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-64|114|616|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-65|114|623|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-66|114|623|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-67|114|651|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-68|114|693|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-69|114|700|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-70|114|700|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-71|114|707|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-72|114|714|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-73|114|721|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-74|114|735|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-75|114|742|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-76|114|749|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-77|114|749|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-78|114|777|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-79|114|777|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-80|114|784|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-81|114|784|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-82|114|784|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-83|114|791|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-84|114|791|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-85|114|791|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-86|114|791|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-87|114|791|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-88|114|805|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-89|114|812|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-90|114|812|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 266 - fibroadenoma|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-91|114|826|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-92|114|826|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-93|114|826|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-94|114|840|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-95|114|847|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-96|114|847|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-97|114|854|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-98|114|854|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-99|114|854|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-100|114|854|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  2,MPATH: 268 - adenocarcinoma|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-101|114|854|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-102|114|868|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-103|114|868|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-104|114|875|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-105|114|882|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-106|114|889|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-107|114|889|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-108|114|917|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-109|114|945|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-110|114|959|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-111|114|966|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-112|114|966|Other deterministic changes|Mammary gland|n/a|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-113|114|987|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  0,MPATH: 266 - fibroadenoma|
11-1-114|Bn-Gy 0,AB00_007.0A5NIH AB00_007.0A0NIH AB00_007.0AXNIH|1| 56|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|114 (114 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-114-114|114|1001|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-1|115|329|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-2|115|588|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-3|115|266|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-4|115|329|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-5|115|392|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-6|115|287|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-7|115|392|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-8|115|392|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-9|115|420|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-10|115|392|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-11|115|392|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-12|115|406|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-13|115|385|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-14|115|392|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-15|115|434|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-16|115|539|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-17|115|518|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-18|115|595|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-19|115|308|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-20|115|455|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-21|115|245|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-22|115|238|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-23|115|413|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-24|115|427|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-25|115|245|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-26|115|357|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-27|115|497|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-28|115|371|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-29|115|518|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-30|115|427|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-31|115|364|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-32|115|371|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-33|115|455|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-34|115|413|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-35|115|490|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-36|115|567|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-37|115|287|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-38|115|385|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-39|115|357|Other deterministic changes|Mammary gland|n/a|
11-1-115|BnOe-Gy 0,AB00_007.0B0NIH|1| 49|estrogen|2|milligrams|Injection, paratibial| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-115-40|115|175|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-1|116|497|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-2|116|546|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-3|116|588|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-4|116|602|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-5|116|602|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-6|116|609|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-7|116|616|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-8|116|616|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-9|116|630|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-10|116|630|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-11|116|630|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-12|116|630|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-13|116|637|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-14|116|644|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-15|116|651|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-16|116|651|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-17|116|651|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-18|116|651|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-19|116|651|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-20|116|665|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-21|116|665|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-22|116|672|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-23|116|686|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-24|116|686|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-25|116|686|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-26|116|700|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-27|116|700|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-28|116|700|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-29|116|700|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-30|116|714|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-31|116|714|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-32|116|714|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-33|116|714|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-34|116|735|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-35|116|735|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-36|116|742|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-37|116|742|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-38|116|742|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-39|116|749|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-40|116|763|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-41|116|770|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-42|116|798|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-43|116|798|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-44|116|798|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-45|116|805|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-46|116|812|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-47|116|819|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-48|116|847|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-49|116|847|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-50|116|861|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-51|116|861|Other deterministic changes|Mammary gland|n/a|
11-1-116|BnOv-Gy 0,AB00_007.0C0NIH|1| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|52 (52 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-116-52|116|896|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-1|117|539|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-2|117|812|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-3|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-4|117|364|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-5|117|343|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-6|117|665|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-7|117|623|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-8|117|420|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-9|117|623|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-10|117|700|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-11|117|679|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-12|117|469|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-13|117|469|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-14|117|616|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-15|117|658|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-16|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-17|117|567|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-18|117|686|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-19|117|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-20|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-21|117|483|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-22|117|336|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-23|117|413|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-24|117|413|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-25|117|371|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-26|117|420|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-27|117|329|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-28|117|434|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-29|117|483|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-30|117|364|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-31|117|462|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-32|117|525|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-33|117|434|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-34|117|644|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-35|117|686|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-36|117|476|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-37|117|455|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-38|117|392|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-39|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-40|117|483|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-41|117|518|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|1| 49|estrogen|2|milligrams|Implantation| n/a|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-42|117|567|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-1|117|539|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-2|117|812|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-3|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-4|117|364|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-5|117|343|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-6|117|665|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-7|117|623|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-8|117|420|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-9|117|623|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-10|117|700|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-11|117|679|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-12|117|469|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-13|117|469|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-14|117|616|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-15|117|658|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-16|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-17|117|567|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-18|117|686|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-19|117|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-20|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-21|117|483|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-22|117|336|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-23|117|413|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-24|117|413|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-25|117|371|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-26|117|420|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-27|117|329|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-28|117|434|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-29|117|483|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-30|117|364|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-31|117|462|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-32|117|525|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-33|117|434|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-34|117|644|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-35|117|686|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-36|117|476|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-37|117|455|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-38|117|392|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-39|117|399|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-40|117|483|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-41|117|518|Other deterministic changes|Mammary gland|n/a|
11-1-117|BnOeOv-Gy 0,AB00_007.0D0NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|42 (42 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-117-42|117|567|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-1|118|434|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-2|118|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-3|118|525|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-4|118|553|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-5|118|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 266 - fibroadenoma|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-6|118|637|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-7|118|658|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-8|118|693|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-9|118|707|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-10|118|714|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-11|118|735|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-12|118|749|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-13|118|763|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-14|118|763|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-15|118|770|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-16|118|798|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-17|118|812|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-18|118|833|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-19|118|854|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-20|118|854|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-21|118|854|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-22|118|861|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-23|118|861|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-24|118|861|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-25|118|882|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-26|118|882|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-27|118|889|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-28|118|896|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-29|118|903|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-30|118|917|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-31|118|924|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-32|118|931|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-33|118|931|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-34|118|931|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-35|118|931|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-36|118|938|Other deterministic changes|Mammary gland|n/a|
11-1-118|XBn-Gy 0.25,ABXT_116.IA1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|37 (37 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-118-37|118|1092|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-1|119|406|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-2|119|420|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-3|119|448|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-4|119|399|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-5|119|385|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-6|119|679|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-7|119|497|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-8|119|693|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-9|119|224|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-10|119|490|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-11|119|427|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-12|119|469|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-13|119|350|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-14|119|266|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-15|119|322|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-16|119|315|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-17|119|623|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-18|119|238|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-19|119|427|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-20|119|693|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-21|119|385|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-22|119|357|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-23|119|560|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-24|119|483|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-25|119|413|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-26|119|378|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-27|119|693|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-28|119|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-29|119|448|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-30|119|203|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-31|119|399|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-32|119|469|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-33|119|294|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-34|119|189|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-35|119|350|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-36|119|224|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-37|119|546|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-38|119|623|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-39|119|623|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-40|119|497|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-1|119|406|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-2|119|420|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-3|119|448|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-4|119|399|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-5|119|385|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-6|119|679|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-7|119|497|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-8|119|693|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-9|119|224|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-10|119|490|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-11|119|427|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-12|119|469|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-13|119|350|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-14|119|266|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-15|119|322|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-16|119|315|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-17|119|623|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-18|119|238|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-19|119|427|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-20|119|693|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-21|119|385|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-22|119|357|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-23|119|560|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-24|119|483|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-25|119|413|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-26|119|378|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-27|119|693|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-28|119|693|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-29|119|448|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-30|119|203|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-31|119|399|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-32|119|469|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-33|119|294|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-34|119|189|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-35|119|350|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-36|119|224|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-37|119|546|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-38|119|623|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-39|119|623|Other deterministic changes|Mammary gland|n/a|
11-1-119|XBnOe-Gy 0.25,ABXT_116.IB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-119-40|119|497|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-1|120|406|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-2|120|539|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-3|120|560|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-4|120|567|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-5|120|602|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-6|120|616|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-7|120|616|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-8|120|623|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-9|120|637|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-10|120|651|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-11|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-12|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-13|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-14|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-15|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-16|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-17|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-18|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-19|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-20|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-21|120|672|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-22|120|672|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-23|120|679|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-24|120|679|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-25|120|679|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-26|120|693|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-27|120|693|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-28|120|693|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-29|120|714|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-30|120|749|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-31|120|784|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-32|120|791|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-33|120|847|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-34|120|861|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-35|120|861|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-36|120|924|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-37|120|924|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-38|120|924|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-1|120|406|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-2|120|539|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-3|120|560|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-4|120|567|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-5|120|602|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-6|120|616|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-7|120|616|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-8|120|623|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-9|120|637|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-10|120|651|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-11|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-12|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-13|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-14|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-15|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-16|120|658|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-17|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-18|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-19|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-20|120|665|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-21|120|672|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-22|120|672|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-23|120|679|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-24|120|679|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-25|120|679|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-26|120|693|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-27|120|693|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-28|120|693|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-29|120|714|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-30|120|749|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-31|120|784|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-32|120|791|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-33|120|847|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-34|120|861|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-35|120|861|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-36|120|924|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-37|120|924|Other deterministic changes|Mammary gland|n/a|
11-1-120|XBnOv-Gy 0.25,ABXT_116.IC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-120-38|120|924|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-1|121|322|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-2|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-3|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-4|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-5|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-6|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-7|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-8|121|490|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-9|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-10|121|273|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-11|121|329|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-12|121|322|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-13|121|245|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-14|121|504|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-15|121|532|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-16|121|595|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-17|121|553|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-18|121|448|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-19|121|427|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-20|121|371|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-21|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-22|121|252|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-23|121|525|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-24|121|462|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-25|121|462|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-26|121|518|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-27|121|714|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-28|121|413|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-29|121|413|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-30|121|280|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-31|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-32|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-33|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-34|121|238|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-35|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-36|121|651|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-37|121|630|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-38|121|399|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-39|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|1| 56|X-rays whole body|0.25|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-40|121|602|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-1|121|322|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-2|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-3|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-4|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-5|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-6|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-7|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-8|121|490|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-9|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-10|121|273|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-11|121|329|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-12|121|322|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-13|121|245|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-14|121|504|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-15|121|532|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-16|121|595|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-17|121|553|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-18|121|448|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-19|121|427|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-20|121|371|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-21|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-22|121|252|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-23|121|525|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-24|121|462|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-25|121|462|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-26|121|518|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-27|121|714|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-28|121|413|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-29|121|413|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-30|121|280|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-31|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-32|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-33|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-34|121|238|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-35|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-36|121|651|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-37|121|630|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-38|121|399|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-39|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-40|121|602|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-1|121|322|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-2|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-3|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-4|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-5|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-6|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-7|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-8|121|490|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-9|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-10|121|273|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-11|121|329|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-12|121|322|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-13|121|245|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-14|121|504|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-15|121|532|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-16|121|595|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-17|121|553|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-18|121|448|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-19|121|427|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-20|121|371|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-21|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-22|121|252|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-23|121|525|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-24|121|462|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-25|121|462|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-26|121|518|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-27|121|714|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-28|121|413|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-29|121|413|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-30|121|280|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-31|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-32|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-33|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-34|121|238|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-35|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-36|121|651|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-37|121|630|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-38|121|399|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-39|121|406|Other deterministic changes|Mammary gland|n/a|
11-1-121|XBnOeOv-Gy 0.25,ABXT_116.ID1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-121-40|121|602|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-1|122|322|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-2|122|343|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-3|122|357|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-4|122|357|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-5|122|392|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-6|122|392|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-7|122|392|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-8|122|413|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-9|122|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-10|122|413|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-11|122|413|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-12|122|427|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-13|122|434|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-14|122|434|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-15|122|441|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-16|122|441|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-17|122|441|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-18|122|441|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-19|122|441|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-20|122|490|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-21|122|490|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-22|122|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-23|122|511|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-24|122|518|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-25|122|518|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-26|122|532|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-27|122|532|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-28|122|553|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-29|122|560|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-30|122|567|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-31|122|567|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-32|122|581|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-33|122|581|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-34|122|588|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-35|122|595|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-36|122|595|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-37|122|609|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-38|122|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-39|122|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-40|122|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-41|122|707|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-42|122|707|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-43|122|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-44|122|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-45|122|735|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-46|122|770|Other deterministic changes|Mammary gland|n/a|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-47|122|854|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-48|122|889|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-122|XBn-Gy 1,ABXT_116.OA5NIH ABXT_116.OA2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|49 (49 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-122-49|122|959|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-1|123|672|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-2|123|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-3|123|210|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-4|123|490|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-5|123|595|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-6|123|364|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-7|123|476|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-8|123|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-9|123|448|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-10|123|399|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-11|123|511|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-12|123|357|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-13|123|406|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-14|123|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-15|123|196|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-16|123|567|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-17|123|245|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-18|123|399|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-19|123|497|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-20|123|210|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-1|123|672|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-2|123|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-3|123|210|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-4|123|490|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-5|123|595|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-6|123|364|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-7|123|476|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-8|123|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-9|123|448|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-10|123|399|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-11|123|511|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-12|123|357|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-13|123|406|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-14|123|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 268 - adenocarcinoma|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-15|123|196|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-16|123|567|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-17|123|245|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-18|123|399|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-19|123|497|Other deterministic changes|Mammary gland|n/a|
11-1-123|XBnOe-Gy 1,ABXT_116.OB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-123-20|123|210|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-1|124|315|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-2|124|518|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-3|124|525|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-4|124|567|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-5|124|574|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-6|124|581|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-7|124|623|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-8|124|651|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-9|124|651|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-10|124|658|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-11|124|672|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-12|124|693|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-13|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-14|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-15|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-16|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-17|124|742|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-18|124|742|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-19|124|840|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-20|124|840|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-1|124|315|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-2|124|518|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-3|124|525|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-4|124|567|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-5|124|574|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-6|124|581|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-7|124|623|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-8|124|651|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-9|124|651|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-10|124|658|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-11|124|672|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-12|124|693|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-13|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-14|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-15|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-16|124|700|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-17|124|742|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-18|124|742|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-19|124|840|Other deterministic changes|Mammary gland|n/a|
11-1-124|XBnOv-Gy 1,ABXT_116.OC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-124-20|124|840|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-1|125|539|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-2|125|700|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-3|125|602|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-4|125|525|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-5|125|476|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-6|125|476|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-7|125|546|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-8|125|546|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-9|125|441|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-10|125|700|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-11|125|651|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-12|125|595|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-13|125|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-14|125|581|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-15|125|399|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-16|125|637|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-17|125|581|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-18|125|644|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-19|125|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|1| 56|X-rays whole body|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-20|125|539|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-1|125|539|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-2|125|700|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-3|125|602|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-4|125|525|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-5|125|476|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-6|125|476|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-7|125|546|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-8|125|546|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-9|125|441|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-10|125|700|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-11|125|651|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-12|125|595|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-13|125|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-14|125|581|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-15|125|399|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-16|125|637|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-17|125|581|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-18|125|644|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-19|125|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-20|125|539|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-1|125|539|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-2|125|700|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-3|125|602|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-4|125|525|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-5|125|476|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-6|125|476|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-7|125|546|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-8|125|546|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-9|125|441|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-10|125|700|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-11|125|651|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-12|125|595|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-13|125|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-14|125|581|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-15|125|399|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-16|125|637|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-17|125|581|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-18|125|644|Other deterministic changes|Mammary gland|n/a|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-19|125|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-125|XBnOeOv-Gy 1,ABXT_116.OD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-125-20|125|539|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-1|126|203|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-2|126|259|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-3|126|322|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-4|126|322|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-5|126|322|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-6|126|343|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-7|126|350|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-8|126|371|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-9|126|371|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-10|126|371|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-11|126|385|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-12|126|385|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-13|126|392|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-14|126|392|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-15|126|399|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-16|126|399|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-17|126|406|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-18|126|406|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-19|126|427|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-20|126|427|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-21|126|441|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-22|126|441|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-23|126|441|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-24|126|448|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-25|126|462|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-26|126|462|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-27|126|469|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-28|126|469|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-29|126|504|Other deterministic changes|Mammary gland|n/a|
11-1-126|XBn-Gy 2,ABXT_116.QA6NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|20 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-126-30|126|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-1|127|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-2|127|525|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-3|127|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-4|127|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-5|127|518|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-6|127|518|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-7|127|476|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-8|127|567|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-9|127|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-10|127|504|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-11|127|371|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-12|127|490|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-13|127|371|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-14|127|434|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-15|127|532|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-16|127|532|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-17|127|637|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-18|127|364|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|1| 56|X-rays whole body|2|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-19|127|427|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-1|127|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-2|127|525|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-3|127|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-4|127|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-5|127|518|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-6|127|518|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-7|127|476|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-8|127|567|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-9|127|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-10|127|504|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-11|127|371|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-12|127|490|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-13|127|371|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-14|127|434|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-15|127|532|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-16|127|532|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-17|127|637|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-18|127|364|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-19|127|427|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-1|127|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-2|127|525|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-3|127|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-4|127|700|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-5|127|518|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-6|127|518|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-7|127|476|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-8|127|567|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-9|127|651|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-10|127|504|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-11|127|371|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-12|127|490|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-13|127|371|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-14|127|434|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-15|127|532|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-16|127|532|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-17|127|637|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-18|127|364|Other deterministic changes|Mammary gland|n/a|
11-1-127|XBnOeOv-Gy 2,ABXT_116.QD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-127-19|127|427|Other deterministic changes|Mammary gland|n/a|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-1|128|371|Other deterministic changes|Mammary gland|n/a|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-2|128|378|Other deterministic changes|Mammary gland|n/a|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-3|128|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-4|128|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-5|128|469|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-6|128|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-7|128|497|Other deterministic changes|Mammary gland|n/a|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-8|128|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-9|128|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-10|128|637|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-11|128|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  6,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-12|128|651|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-13|128|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-14|128|665|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-15|128|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-16|128|707|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-17|128|721|Other deterministic changes|Mammary gland|n/a|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-18|128|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-128|XBn-Gy 4,ABXT_116.RA3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-128-19|128|763|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-1|129|371|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-2|129|511|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-3|129|266|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-4|129|476|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-5|129|308|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-6|129|511|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-7|129|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-8|129|511|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-9|129|294|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-10|129|210|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-11|129|210|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-12|129|679|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-13|129|175|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-14|129|371|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-15|129|469|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-16|129|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-17|129|413|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-18|129|231|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-19|129|469|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-20|129|434|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-21|129|238|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-22|129|413|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-23|129|497|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-24|129|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-25|129|490|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-26|129|581|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-27|129|434|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-28|129|364|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-29|129|637|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-30|129|637|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-31|129|287|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-32|129|322|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-33|129|434|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-1|129|371|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-2|129|511|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-3|129|266|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-4|129|476|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-5|129|308|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-6|129|511|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-7|129|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-8|129|511|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-9|129|294|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-10|129|210|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-11|129|210|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-12|129|679|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-13|129|175|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-14|129|371|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-15|129|469|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-16|129|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-17|129|413|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-18|129|231|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-19|129|469|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-20|129|434|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-21|129|238|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-22|129|413|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-23|129|497|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-24|129|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-25|129|490|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-26|129|581|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-27|129|434|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-28|129|364|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-29|129|637|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-30|129|637|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-31|129|287|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-32|129|322|Other deterministic changes|Mammary gland|n/a|
11-1-129|XBnOe-Gy 4,ABXT_116.RB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|33 (33 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-129-33|129|434|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-1|130|273|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-2|130|406|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-3|130|448|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-4|130|455|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-5|130|539|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-6|130|553|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-7|130|574|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-8|130|602|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-9|130|609|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-10|130|616|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-11|130|630|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-12|130|644|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-13|130|651|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-14|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-15|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-16|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-17|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-18|130|679|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-19|130|686|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-20|130|714|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-21|130|714|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-22|130|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-23|130|735|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-24|130|735|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-25|130|763|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-26|130|784|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-27|130|784|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-28|130|791|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-29|130|805|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-30|130|924|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-1|130|273|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-2|130|406|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-3|130|448|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-4|130|455|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-5|130|539|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-6|130|553|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-7|130|574|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-8|130|602|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-9|130|609|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-10|130|616|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-11|130|630|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-12|130|644|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-13|130|651|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-14|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-15|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-16|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-17|130|665|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-18|130|679|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-19|130|686|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-20|130|714|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-21|130|714|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-22|130|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-23|130|735|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-24|130|735|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-25|130|763|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-26|130|784|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-27|130|784|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-28|130|791|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-29|130|805|Other deterministic changes|Mammary gland|n/a|
11-1-130|XBnOv-Gy 4,ABXT_116.RC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|30 (30 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-130-30|130|924|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-1|131|413|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-2|131|518|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-3|131|539|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-4|131|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-5|131|476|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-6|131|434|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-7|131|336|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-8|131|413|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-9|131|602|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-10|131|427|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-11|131|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-12|131|581|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-13|131|476|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-14|131|483|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-15|131|371|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-16|131|441|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-17|131|539|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-18|131|350|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-19|131|651|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-20|131|511|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-21|131|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-22|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-23|131|343|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-24|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-25|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-26|131|497|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-27|131|490|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-28|131|504|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|1| 56|X-rays whole body|4|grays|External exposure| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-29|131|511|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-1|131|413|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-2|131|518|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-3|131|539|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-4|131|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-5|131|476|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-6|131|434|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-7|131|336|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-8|131|413|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-9|131|602|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-10|131|427|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-11|131|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-12|131|581|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-13|131|476|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-14|131|483|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-15|131|371|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-16|131|441|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-17|131|539|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-18|131|350|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-19|131|651|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-20|131|511|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-21|131|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-22|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-23|131|343|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-24|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-25|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-26|131|497|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-27|131|490|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-28|131|504|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-29|131|511|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-1|131|413|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-2|131|518|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-3|131|539|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-4|131|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-5|131|476|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-6|131|434|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-7|131|336|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-8|131|413|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-9|131|602|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-10|131|427|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-11|131|441|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-12|131|581|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-13|131|476|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-14|131|483|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-15|131|371|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-16|131|441|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-17|131|539|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-18|131|350|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-19|131|651|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-20|131|511|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-21|131|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-22|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-23|131|343|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-24|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-25|131|546|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-26|131|497|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-27|131|490|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-28|131|504|Other deterministic changes|Mammary gland|n/a|
11-1-131|XBnOeOv-Gy 4,ABXT_116.RD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|29 (29 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-131-29|131|511|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-1|132|231|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-2|132|266|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-3|132|301|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-4|132|378|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-5|132|378|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-6|132|399|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-7|132|406|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-8|132|406|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-9|132|448|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-10|132|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-11|132|469|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-12|132|469|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-13|132|476|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-14|132|476|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-15|132|504|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-16|132|504|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-17|132|504|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-18|132|504|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-19|132|511|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-20|132|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-21|132|525|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-22|132|532|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-23|132|532|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-24|132|539|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-25|132|546|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-26|132|581|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-27|132|588|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-28|132|588|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-29|132|609|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-30|132|616|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-31|132|616|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-32|132|616|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-33|132|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-34|132|651|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-35|132|658|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-36|132|658|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-37|132|679|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-38|132|686|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-39|132|686|Other deterministic changes|Mammary gland|n/a|
11-1-132|N.5Bn-Gy 0.005,ABHT_116.CA1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-132-40|132|756|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-1|133|427|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-2|133|252|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-3|133|224|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-4|133|350|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-5|133|448|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-6|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-7|133|399|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-8|133|329|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-9|133|343|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-10|133|574|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-11|133|301|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-12|133|609|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-13|133|567|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-14|133|364|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-15|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-16|133|287|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-17|133|350|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-18|133|574|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-19|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-20|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-21|133|455|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-22|133|455|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-23|133|294|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-24|133|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-25|133|343|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-26|133|413|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-27|133|294|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-28|133|301|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-29|133|693|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-30|133|273|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-31|133|679|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-32|133|399|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-33|133|280|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-34|133|378|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-35|133|210|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-36|133|280|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-37|133|441|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-38|133|434|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-39|133|532|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-40|133|357|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-1|133|427|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-2|133|252|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-3|133|224|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-4|133|350|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-5|133|448|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-6|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-7|133|399|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-8|133|329|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-9|133|343|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-10|133|574|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-11|133|301|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-12|133|609|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-13|133|567|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-14|133|364|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-15|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-16|133|287|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-17|133|350|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-18|133|574|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-19|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-20|133|504|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-21|133|455|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-22|133|455|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-23|133|294|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-24|133|504|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-25|133|343|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-26|133|413|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-27|133|294|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-28|133|301|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-29|133|693|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-30|133|273|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-31|133|679|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-32|133|399|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-33|133|280|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-34|133|378|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-35|133|210|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-36|133|280|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-37|133|441|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-38|133|434|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-39|133|532|Other deterministic changes|Mammary gland|n/a|
11-1-133|N.5BnOe-Gy 0.005,ABHT_116.CB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-133-40|133|357|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-1|134|252|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-2|134|266|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-3|134|273|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-4|134|294|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-5|134|294|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-6|134|308|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-7|134|308|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-8|134|315|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-9|134|322|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-10|134|329|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-11|134|357|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-12|134|364|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-13|134|371|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-14|134|385|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-15|134|385|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-16|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-17|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-18|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-19|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-20|134|406|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-21|134|441|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-22|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-23|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-24|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-25|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-26|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-27|134|455|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-28|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-29|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-30|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-31|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-32|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-33|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-34|134|497|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-35|134|504|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-36|134|504|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-37|134|511|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-38|134|518|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-39|134|532|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-40|134|595|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-1|134|252|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-2|134|266|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-3|134|273|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-4|134|294|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-5|134|294|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-6|134|308|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-7|134|308|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-8|134|315|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-9|134|322|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-10|134|329|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-11|134|357|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-12|134|364|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-13|134|371|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-14|134|385|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-15|134|385|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-16|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-17|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-18|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-19|134|392|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-20|134|406|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-21|134|441|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-22|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-23|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-24|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-25|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-26|134|448|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-27|134|455|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-28|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-29|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-30|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-31|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-32|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-33|134|462|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-34|134|497|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-35|134|504|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-36|134|504|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-37|134|511|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-38|134|518|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-39|134|532|Other deterministic changes|Mammary gland|n/a|
11-1-134|N.5BnOv-Gy 0.005,ABHT_116.CC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-134-40|134|595|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-1|135|406|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-2|135|567|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-3|135|700|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-4|135|707|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-5|135|406|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-6|135|700|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-7|135|448|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-8|135|539|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-9|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-10|135|518|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-11|135|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-12|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-13|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-14|135|301|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-15|135|623|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-16|135|595|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-17|135|308|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-18|135|469|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-19|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-20|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-21|135|329|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-22|135|462|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-23|135|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-24|135|546|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-25|135|336|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-26|135|483|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-27|135|441|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-28|135|301|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-29|135|770|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-30|135|525|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-31|135|350|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-32|135|441|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-33|135|630|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-34|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-35|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-36|135|623|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-37|135|518|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-38|135|399|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-39|135|721|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-40|135|315|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|1| 56|accel. neutrons 0.1-10 MeV|0.005|grays|External exposure| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-41|135|483|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-1|135|406|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-2|135|567|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-3|135|700|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-4|135|707|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-5|135|406|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-6|135|700|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-7|135|448|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-8|135|539|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-9|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-10|135|518|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-11|135|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-12|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-13|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-14|135|301|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-15|135|623|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-16|135|595|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-17|135|308|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-18|135|469|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-19|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-20|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-21|135|329|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-22|135|462|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-23|135|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-24|135|546|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-25|135|336|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-26|135|483|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-27|135|441|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-28|135|301|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-29|135|770|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-30|135|525|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-31|135|350|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-32|135|441|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-33|135|630|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-34|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-35|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-36|135|623|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-37|135|518|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-38|135|399|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-39|135|721|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-40|135|315|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-41|135|483|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-1|135|406|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-2|135|567|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-3|135|700|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-4|135|707|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-5|135|406|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-6|135|700|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-7|135|448|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-8|135|539|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-9|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-10|135|518|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-11|135|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-12|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-13|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-14|135|301|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-15|135|623|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-16|135|595|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-17|135|308|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-18|135|469|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-19|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-20|135|455|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-21|135|329|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-22|135|462|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-23|135|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-24|135|546|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-25|135|336|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-26|135|483|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-27|135|441|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-28|135|301|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-29|135|770|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-30|135|525|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-31|135|350|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-32|135|441|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-33|135|630|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-34|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-35|135|679|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-36|135|623|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-37|135|518|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-38|135|399|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-39|135|721|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-40|135|315|Other deterministic changes|Mammary gland|n/a|
11-1-135|N.5BnOeOv-Gy 0.05,ABHT_116.CD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|41 (41 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-135-41|135|483|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-1|136|238|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-2|136|266|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-3|136|273|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-4|136|301|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-5|136|315|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-6|136|315|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-7|136|322|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-8|136|322|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-9|136|329|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-10|136|329|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-11|136|343|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-12|136|350|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-13|136|350|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-14|136|357|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-15|136|371|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-16|136|392|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-17|136|399|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-18|136|399|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-19|136|399|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-20|136|399|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-21|136|399|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-22|136|406|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-23|136|413|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-24|136|420|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-25|136|420|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-26|136|420|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-27|136|427|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-28|136|427|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-29|136|427|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-30|136|434|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-31|136|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-32|136|462|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-33|136|462|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-34|136|469|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-35|136|469|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-36|136|476|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-37|136|476|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-38|136|483|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-39|136|497|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-40|136|497|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-41|136|504|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-42|136|504|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-43|136|511|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-44|136|518|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-45|136|539|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-46|136|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-47|136|539|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-48|136|546|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-49|136|546|Other deterministic changes|Mammary gland|n/a|
11-1-136|NN.5Bn-Gy 0.02,ABHT-116.HA2/HA5NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-136-50|136|182|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-1|137|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-2|137|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-3|137|294|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-4|137|511|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-5|137|357|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-6|137|469|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-7|137|525|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-8|137|427|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-9|137|511|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-10|137|434|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-11|137|672|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-12|137|469|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-13|137|560|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-14|137|602|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-15|137|588|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-16|137|560|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-17|137|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-18|137|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-19|137|77|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-20|137|168|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-1|137|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-2|137|385|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 268 - adenocarcinoma|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-3|137|294|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-4|137|511|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-5|137|357|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-6|137|469|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-7|137|525|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-8|137|427|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-9|137|511|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-10|137|434|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-11|137|672|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-12|137|469|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-13|137|560|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-14|137|602|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-15|137|588|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-16|137|560|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-17|137|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-18|137|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 218 - neoplasm|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-19|137|77|Other deterministic changes|Mammary gland|n/a|
11-1-137|N.5BnOe-Gy 0.02,ABHT_116.HB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-137-20|137|168|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-1|138|294|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-2|138|301|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-3|138|371|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-4|138|378|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-5|138|378|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-6|138|385|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-7|138|406|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-8|138|413|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-9|138|448|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-10|138|462|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-11|138|469|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-12|138|469|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-13|138|476|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-14|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-15|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-16|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-17|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-18|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-19|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-20|138|539|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-1|138|294|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-2|138|301|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-3|138|371|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-4|138|378|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-5|138|378|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-6|138|385|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-7|138|406|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-8|138|413|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-9|138|448|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-10|138|462|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-11|138|469|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-12|138|469|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-13|138|476|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-14|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-15|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-16|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-17|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-18|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-19|138|490|Other deterministic changes|Mammary gland|n/a|
11-1-138|N.5BnOv-Gy 0.02,ABHT_116.HC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-138-20|138|539|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-1|139|448|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-2|139|448|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-3|139|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-4|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-5|139|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-6|139|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-7|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-8|139|532|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-9|139|308|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-10|139|511|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-11|139|504|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-12|139|672|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-13|139|665|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-14|139|357|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-15|139|343|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-16|139|406|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-17|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-18|139|518|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-19|139|518|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|1| 56|accel. neutrons 0.1-10 MeV|0.02|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-20|139|616|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-1|139|448|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-2|139|448|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-3|139|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-4|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-5|139|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-6|139|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-7|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-8|139|532|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-9|139|308|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-10|139|511|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-11|139|504|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-12|139|672|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-13|139|665|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-14|139|357|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-15|139|343|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-16|139|406|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-17|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-18|139|518|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-19|139|518|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-20|139|616|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-1|139|448|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-2|139|448|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-3|139|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-4|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-5|139|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-6|139|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-7|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-8|139|532|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-9|139|308|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-10|139|511|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-11|139|504|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-12|139|672|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-13|139|665|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-14|139|357|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-15|139|343|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-16|139|406|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-17|139|588|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-18|139|518|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-19|139|518|Other deterministic changes|Mammary gland|n/a|
11-1-139|N.5BnOeOv-Gy 0.02,ABHT_116.HD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-139-20|139|616|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-1|140|322|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-2|140|301|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-3|140|371|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-4|140|371|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-5|140|413|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-6|140|343|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-7|140|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-8|140|399|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-9|140|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 266 - fibroadenoma|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-10|140|511|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-11|140|357|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-12|140|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-13|140|371|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-14|140|609|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-15|140|483|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-16|140|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-17|140|357|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-18|140|301|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-19|140|385|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|1| 56|accel. neutrons 0.1-10 MeV|0.05|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-20|140|399|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-1|140|322|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-2|140|301|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-3|140|371|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-4|140|371|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-5|140|413|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-6|140|343|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-7|140|455|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-8|140|399|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-9|140|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  9,MPATH: 266 - fibroadenoma|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-10|140|511|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-11|140|357|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-12|140|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 266 - fibroadenoma|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-13|140|371|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-14|140|609|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-15|140|483|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-16|140|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-17|140|357|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-18|140|301|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-19|140|385|Other deterministic changes|Mammary gland|n/a|
11-1-140|N.5BnOe-Gy 0.05,ABHT_116.MB4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-140-20|140|399|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-1|141|238|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 5 Size  9,MPATH: 268 - adenocarcinoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-2|141|371|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-3|141|371|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-4|141|371|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-5|141|371|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-6|141|406|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-7|141|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-8|141|441|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-9|141|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-10|141|483|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-11|141|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-12|141|532|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-13|141|539|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-14|141|539|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-15|141|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-16|141|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-17|141|567|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-18|141|602|Other deterministic changes|Mammary gland|n/a|
11-1-141|N.5Bn-Gy 0.08,ABHT_116.NA3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-141-19|141|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-1|142|357|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-2|142|462|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-3|142|476|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-4|142|434|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-5|142|287|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-6|142|280|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-7|142|455|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-8|142|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-9|142|483|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-10|142|280|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-11|142|553|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-12|142|553|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-13|142|357|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-14|142|462|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-15|142|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-16|142|560|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-17|142|518|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-18|142|315|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-19|142|308|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-20|142|147|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-1|142|357|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-2|142|462|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-3|142|476|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-4|142|434|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-5|142|287|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-6|142|280|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-7|142|455|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-8|142|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-9|142|483|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-10|142|280|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-11|142|553|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-12|142|553|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-13|142|357|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-14|142|462|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-15|142|574|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-16|142|560|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-17|142|518|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-18|142|315|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-19|142|308|Other deterministic changes|Mammary gland|n/a|
11-1-142|N.5BnOe-Gy 0.08,ABHT_116.NB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-142-20|142|147|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-1|143|315|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-2|143|357|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-3|143|385|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-4|143|427|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-5|143|427|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-6|143|427|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-7|143|427|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-8|143|434|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-9|143|434|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-10|143|441|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-11|143|441|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-12|143|497|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-13|143|504|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-14|143|504|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-15|143|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-16|143|518|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-17|143|532|Other deterministic changes|Mammary gland|n/a|
11-1-143|N.5BnOv-Gy 0.08,ABHT_116.NC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-143-18|143|133|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-1|144|616|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-2|144|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-3|144|399|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-4|144|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-5|144|406|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-6|144|581|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-7|144|378|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-8|144|371|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-9|144|609|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-10|144|196|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-11|144|399|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-12|144|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-13|144|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-14|144|392|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-15|144|511|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-16|144|378|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-17|144|469|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-18|144|504|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|1| 56|accel. neutrons 0.1-10 MeV|0.08|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-19|144|287|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-1|144|616|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-2|144|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-3|144|399|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-4|144|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-5|144|406|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-6|144|581|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-7|144|378|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-8|144|371|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-9|144|609|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-10|144|196|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-11|144|399|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-12|144|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-13|144|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-14|144|392|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-15|144|511|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-16|144|378|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-17|144|469|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-18|144|504|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-19|144|287|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-1|144|616|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-2|144|406|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-3|144|399|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-4|144|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  8,MPATH: 268 - adenocarcinoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-5|144|406|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-6|144|581|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-7|144|378|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-8|144|371|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-9|144|609|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-10|144|196|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-11|144|399|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-12|144|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-13|144|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-14|144|392|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-15|144|511|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-16|144|378|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-17|144|469|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-18|144|504|Other deterministic changes|Mammary gland|n/a|
11-1-144|N.5BnOeOv-Gy 0.08,ABHT_116.ND3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-144-19|144|287|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-1|145|189|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-2|145|350|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-3|145|434|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-4|145|462|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-5|145|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 218 - neoplasm|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-6|145|462|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-7|145|462|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-8|145|462|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-9|145|560|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-10|145|560|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-11|145|560|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-12|145|574|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-13|145|609|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-14|145|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-15|145|644|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-16|145|644|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-17|145|672|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-18|145|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-19|145|672|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-20|145|693|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-21|145|700|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-22|145|707|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-23|145|707|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-24|145|735|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-25|145|742|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-26|145|749|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-27|145|756|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-28|145|763|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-29|145|784|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-30|145|791|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-31|145|812|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-32|145|847|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-33|145|854|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-34|145|896|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-35|145|973|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-36|145|1001|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-37|145|1001|Other deterministic changes|Mammary gland|n/a|
11-1-145|N4Bn-Gy 0.1,ABIT_116.EA1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-145-38|145|1015|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-1|146|322|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-2|146|483|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-3|146|483|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-4|146|301|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-5|146|532|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-6|146|476|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-7|146|224|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-8|146|371|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-9|146|483|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-10|146|420|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-11|146|420|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-12|146|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-13|146|322|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-14|146|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-15|146|455|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-16|146|497|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-17|146|357|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-18|146|406|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-19|146|413|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-20|146|413|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-21|146|406|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-22|146|455|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-23|146|434|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-24|146|497|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-25|146|574|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-26|146|406|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-27|146|385|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-28|146|287|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-29|146|364|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-30|146|497|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-31|146|392|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-32|146|602|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-33|146|476|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-34|146|469|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-35|146|462|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-36|146|371|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-37|146|329|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-38|146|364|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-39|146|371|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-40|146|168|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-1|146|322|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-2|146|483|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-3|146|483|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-4|146|301|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-5|146|532|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-6|146|476|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-7|146|224|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-8|146|371|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-9|146|483|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-10|146|420|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-11|146|420|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-12|146|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-13|146|322|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-14|146|539|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 268 - adenocarcinoma|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-15|146|455|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-16|146|497|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-17|146|357|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-18|146|406|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-19|146|413|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-20|146|413|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-21|146|406|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-22|146|455|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-23|146|434|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-24|146|497|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-25|146|574|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-26|146|406|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-27|146|385|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-28|146|287|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-29|146|364|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-30|146|497|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-31|146|392|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-32|146|602|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-33|146|476|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-34|146|469|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-35|146|462|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-36|146|371|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-37|146|329|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-38|146|364|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-39|146|371|Other deterministic changes|Mammary gland|n/a|
11-1-146|N4BnOe-Gy 0.1,ABIT_116.EB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-146-40|146|168|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-1|147|217|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-2|147|259|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-3|147|259|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-4|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-5|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-6|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-7|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-8|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-9|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-10|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-11|147|287|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-12|147|287|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-13|147|294|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-14|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-15|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-16|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-17|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-18|147|315|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-19|147|315|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-20|147|322|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-21|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-22|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-23|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-24|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-25|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-26|147|343|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-27|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-28|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-29|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-30|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-31|147|357|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-32|147|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-33|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-34|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-35|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-36|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-37|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-38|147|406|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-39|147|420|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-40|147|441|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-41|147|441|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-42|147|455|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-43|147|455|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-44|147|483|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-45|147|497|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-46|147|525|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-47|147|539|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-48|147|539|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-49|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-50|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-51|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-52|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-53|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-54|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-55|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-56|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-57|147|581|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-58|147|581|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-59|147|595|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-60|147|595|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-61|147|602|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-62|147|630|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-63|147|637|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-64|147|651|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-65|147|651|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-66|147|651|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-67|147|672|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-68|147|672|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-69|147|686|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-70|147|686|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-71|147|686|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-72|147|693|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-73|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-74|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-75|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-76|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-1|147|217|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-2|147|259|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-3|147|259|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-4|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-5|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-6|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-7|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-8|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-9|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-10|147|273|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-11|147|287|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-12|147|287|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-13|147|294|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-14|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-15|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-16|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-17|147|301|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-18|147|315|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-19|147|315|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-20|147|322|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-21|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-22|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-23|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-24|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-25|147|329|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-26|147|343|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-27|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-28|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-29|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-30|147|350|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-31|147|357|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-32|147|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-33|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-34|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-35|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-36|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-37|147|392|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-38|147|406|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-39|147|420|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-40|147|441|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-41|147|441|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-42|147|455|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-43|147|455|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-44|147|483|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-45|147|497|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-46|147|525|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-47|147|539|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-48|147|539|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-49|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-50|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-51|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-52|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-53|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-54|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-55|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-56|147|546|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-57|147|581|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-58|147|581|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-59|147|595|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-60|147|595|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-61|147|602|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-62|147|630|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-63|147|637|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-64|147|651|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-65|147|651|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-66|147|651|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-67|147|672|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-68|147|672|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-69|147|686|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-70|147|686|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-71|147|686|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-72|147|693|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-73|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-74|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-75|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-147|N4BnOv-Gy 0.1,ABIT_116.EC5NIH ABIT_116.EC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|76 (76 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-147-76|147|735|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-1|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-2|148|420|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-3|148|511|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-4|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-5|148|560|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-6|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-7|148|336|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-8|148|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-9|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-10|148|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-11|148|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-12|148|413|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-13|148|350|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-14|148|525|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-15|148|525|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-16|148|637|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-17|148|385|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-18|148|448|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-19|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-20|148|336|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-21|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-22|148|322|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-23|148|392|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-24|148|532|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-25|148|532|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-26|148|497|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-27|148|735|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-28|148|756|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-29|148|497|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-30|148|441|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-31|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-32|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-33|148|441|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-34|148|469|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-35|148|392|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-36|148|539|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-37|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-38|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|1| 56|neutrons 1-10 MeV|0.1|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-39|148|147|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-1|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-2|148|420|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-3|148|511|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-4|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-5|148|560|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-6|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-7|148|336|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-8|148|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-9|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-10|148|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-11|148|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-12|148|413|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-13|148|350|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-14|148|525|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-15|148|525|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-16|148|637|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-17|148|385|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-18|148|448|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-19|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-20|148|336|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-21|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-22|148|322|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-23|148|392|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-24|148|532|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-25|148|532|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-26|148|497|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-27|148|735|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-28|148|756|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-29|148|497|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-30|148|441|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-31|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-32|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-33|148|441|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-34|148|469|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-35|148|392|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-36|148|539|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-37|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-38|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-39|148|147|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-1|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-2|148|420|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-3|148|511|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-4|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-5|148|560|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-6|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-7|148|336|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-8|148|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-9|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-10|148|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-11|148|679|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-12|148|413|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-13|148|350|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-14|148|525|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-15|148|525|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-16|148|637|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-17|148|385|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-18|148|448|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-19|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-20|148|336|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-21|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-22|148|322|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-23|148|392|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-24|148|532|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-25|148|532|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-26|148|497|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-27|148|735|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-28|148|756|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-29|148|497|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-30|148|441|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-31|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-32|148|315|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-33|148|441|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-34|148|469|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-35|148|392|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-36|148|539|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-37|148|490|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-38|148|679|Other deterministic changes|Mammary gland|n/a|
11-1-148|N4BnOeOv-Gy 0.1,ABIT_116.ED1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-148-39|148|147|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-1|149|259|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-2|149|301|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-3|149|308|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-4|149|308|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-5|149|315|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-6|149|322|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-7|149|322|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-8|149|343|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-9|149|364|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-10|149|385|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-11|149|399|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-12|149|399|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-13|149|420|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-14|149|434|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-15|149|448|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-16|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-17|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-18|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-19|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-20|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-21|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-22|149|462|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-23|149|469|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-24|149|469|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-25|149|476|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-26|149|483|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-27|149|483|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-28|149|483|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-29|149|490|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-30|149|490|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-31|149|504|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-32|149|518|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-33|149|518|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-34|149|574|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-35|149|581|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-36|149|588|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-37|149|602|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-38|149|602|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-39|149|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-40|149|623|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-41|149|665|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-42|149|672|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-43|149|679|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-44|149|693|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-45|149|700|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-46|149|742|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-47|149|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-48|149|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-49|149|763|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-50|149|770|Other deterministic changes|Mammary gland|n/a|
11-1-149|N4Bn-Gy 0.3,ABIT_116.JA2NIH ABIT_116.JA5NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|51 (51 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-149-51|149|777|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-1|150|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 218 - neoplasm|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-2|150|357|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-3|150|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-4|150|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-5|150|448|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-6|150|385|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-7|150|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-8|150|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-9|150|399|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-10|150|336|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-11|150|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-12|150|490|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-13|150|567|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-14|150|455|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-15|150|385|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-16|150|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-17|150|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-18|150|581|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-19|150|581|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-20|150|483|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-1|150|364|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  1,MPATH: 218 - neoplasm|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-2|150|357|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-3|150|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  5,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-4|150|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-5|150|448|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-6|150|385|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-7|150|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-8|150|399|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-9|150|399|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-10|150|336|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-11|150|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-12|150|490|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-13|150|567|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-14|150|455|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-15|150|385|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-16|150|532|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-17|150|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-18|150|581|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-19|150|581|Other deterministic changes|Mammary gland|n/a|
11-1-150|N4BnOe-Gy 0.3,ABIT_116.JB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-150-20|150|483|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-1|151|245|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-2|151|245|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-3|151|259|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-4|151|259|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-5|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-6|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-7|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-8|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-9|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-10|151|294|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-11|151|315|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-12|151|336|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-13|151|336|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-14|151|357|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-15|151|371|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-16|151|378|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-17|151|406|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-18|151|420|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-19|151|427|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-20|151|427|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-21|151|427|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-22|151|441|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-23|151|441|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-24|151|448|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-25|151|455|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-26|151|462|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-27|151|476|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-28|151|476|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-29|151|476|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-30|151|497|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-31|151|525|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-32|151|532|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-33|151|539|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-34|151|539|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-35|151|539|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-36|151|637|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-37|151|637|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-38|151|679|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-39|151|98|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-1|151|245|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-2|151|245|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-3|151|259|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-4|151|259|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-5|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-6|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-7|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-8|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-9|151|273|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-10|151|294|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-11|151|315|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-12|151|336|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-13|151|336|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-14|151|357|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-15|151|371|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-16|151|378|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-17|151|406|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-18|151|420|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-19|151|427|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-20|151|427|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-21|151|427|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-22|151|441|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-23|151|441|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-24|151|448|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-25|151|455|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-26|151|462|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-27|151|476|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-28|151|476|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-29|151|476|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-30|151|497|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-31|151|525|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-32|151|532|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-33|151|539|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-34|151|539|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-35|151|539|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-36|151|637|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-37|151|637|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-38|151|679|Other deterministic changes|Mammary gland|n/a|
11-1-151|N4BnOv-Gy 0.3,ABIT_116.JC6NIH ABIT_116.JC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-151-39|151|98|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-1|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-2|152|469|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-3|152|518|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-4|152|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-5|152|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-6|152|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-7|152|511|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-8|152|462|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-9|152|588|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-10|152|357|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-11|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-12|152|469|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-13|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-14|152|406|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-15|152|259|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-16|152|350|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-17|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-18|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-19|152|231|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|1| 56|neutrons 1-10 MeV|0.3|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-20|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-1|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-2|152|469|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-3|152|518|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-4|152|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-5|152|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-6|152|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-7|152|511|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-8|152|462|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-9|152|588|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-10|152|357|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-11|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-12|152|469|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-13|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-14|152|406|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-15|152|259|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-16|152|350|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-17|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-18|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-19|152|231|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-20|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-1|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-2|152|469|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-3|152|518|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-4|152|574|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-5|152|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-6|152|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-7|152|511|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-8|152|462|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-9|152|588|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-10|152|357|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-11|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-12|152|469|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-13|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-14|152|406|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-15|152|259|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-16|152|350|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-17|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-18|152|574|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-19|152|231|Other deterministic changes|Mammary gland|n/a|
11-1-152|N4BnOeOv-Gy 0.3,ABIT_116.JD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-152-20|152|315|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-1|153|378|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-2|153|399|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-3|153|427|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-4|153|455|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-5|153|462|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-6|153|469|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-7|153|483|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-8|153|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-9|153|567|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-10|153|567|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-11|153|574|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-12|153|616|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-13|153|616|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-14|153|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-15|153|623|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-16|153|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-17|153|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-18|153|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-19|153|756|Other deterministic changes|Mammary gland|n/a|
11-1-153|N4Bn-Gy 1,ABIT_116.OA3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-153-20|153|756|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-1|154|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-2|154|343|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-3|154|469|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-4|154|434|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-5|154|210|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-6|154|189|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-7|154|322|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-8|154|259|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-9|154|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-10|154|427|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-11|154|287|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-12|154|287|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-13|154|504|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-14|154|350|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-15|154|511|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-16|154|427|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-17|154|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-18|154|399|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-19|154|378|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-20|154|168|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-1|154|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-2|154|343|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-3|154|469|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-4|154|434|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-5|154|210|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-6|154|189|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-7|154|322|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 218 - neoplasm|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-8|154|259|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-9|154|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-10|154|427|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-11|154|287|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-12|154|287|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-13|154|504|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-14|154|350|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-15|154|511|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-16|154|427|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-17|154|511|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 268 - adenocarcinoma|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-18|154|399|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-19|154|378|Other deterministic changes|Mammary gland|n/a|
11-1-154|N4BnOe-Gy 1,ABIT_116.OB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-154-20|154|168|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-1|155|336|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-2|155|357|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-3|155|420|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-4|155|441|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-5|155|539|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-6|155|630|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-7|155|630|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-8|155|672|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-9|155|672|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-10|155|686|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-11|155|707|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-12|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-13|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-14|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-15|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-16|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-17|155|721|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-18|155|735|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-19|155|742|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-20|155|770|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-1|155|336|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-2|155|357|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-3|155|420|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-4|155|441|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-5|155|539|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-6|155|630|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-7|155|630|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-8|155|672|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-9|155|672|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-10|155|686|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-11|155|707|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-12|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-13|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-14|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-15|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-16|155|714|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-17|155|721|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-18|155|735|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-19|155|742|Other deterministic changes|Mammary gland|n/a|
11-1-155|N4BnOv-Gy 1,ABIT_116.OC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-155-20|155|770|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-1|156|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-2|156|378|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-3|156|525|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-4|156|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-5|156|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-6|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-7|156|497|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-8|156|658|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-9|156|280|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-10|156|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-11|156|434|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-12|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-13|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-14|156|602|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-15|156|462|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-16|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-17|156|476|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-18|156|476|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-19|156|259|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|1| 56|neutrons 1-10 MeV|1|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-20|156|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-1|156|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-2|156|378|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-3|156|525|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-4|156|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-5|156|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-6|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-7|156|497|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-8|156|658|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-9|156|280|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-10|156|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-11|156|434|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-12|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-13|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-14|156|602|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-15|156|462|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-16|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-17|156|476|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-18|156|476|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-19|156|259|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-20|156|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-1|156|609|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-2|156|378|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-3|156|525|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-4|156|609|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-5|156|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-6|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-7|156|497|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-8|156|658|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-9|156|280|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-10|156|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-11|156|434|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-12|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-13|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-14|156|602|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-15|156|462|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-16|156|504|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-17|156|476|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-18|156|476|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-19|156|259|Other deterministic changes|Mammary gland|n/a|
11-1-156|N4BnOeOv-Gy 1,ABIT_116.OD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-156-20|156|602|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-1|157|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-2|157|308|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-3|157|532|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-4|157|343|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-5|157|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-6|157|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-7|157|630|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-8|157|322|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-9|157|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-10|157|665|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-11|157|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-12|157|497|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-13|157|448|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-14|157|406|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-15|157|497|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-16|157|630|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|1| 56|neutrons 1-10 MeV|1.5|grays|External exposure| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-17|157|399|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-1|157|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-2|157|308|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-3|157|532|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-4|157|343|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-5|157|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-6|157|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-7|157|630|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-8|157|322|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-9|157|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-10|157|665|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-11|157|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-12|157|497|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-13|157|448|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-14|157|406|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-15|157|497|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-16|157|630|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-17|157|399|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-1|157|413|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 218 - neoplasm|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-2|157|308|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-3|157|532|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-4|157|343|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-5|157|602|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-6|157|630|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-7|157|630|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-8|157|322|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-9|157|637|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-10|157|665|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-11|157|497|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  7,MPATH: 266 - fibroadenoma|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-12|157|497|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-13|157|448|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-14|157|406|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-15|157|497|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-16|157|630|Other deterministic changes|Mammary gland|n/a|
11-1-157|N4BnOeOv-Gy 1.5,ABIT_116.PD4NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|17 (17 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-157-17|157|399|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-1|158|301|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 218 - neoplasm|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-2|158|483|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-3|158|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-4|158|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-5|158|658|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-6|158|679|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 268 - adenocarcinoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-7|158|707|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-8|158|728|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-9|158|742|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-10|158|742|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-11|158|742|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-12|158|749|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-13|158|749|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-14|158|770|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-15|158|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-16|158|777|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-17|158|791|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-18|158|805|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-19|158|805|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-20|158|812|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-21|158|819|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-22|158|819|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-23|158|819|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-24|158|819|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-25|158|826|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-26|158|833|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-27|158|840|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-28|158|840|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-29|158|847|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-30|158|847|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-31|158|854|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-32|158|854|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-33|158|861|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-34|158|889|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-35|158|889|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-36|158|903|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-37|158|938|Other deterministic changes|Mammary gland|n/a|
11-1-158|N15Bn-Gy 0.15,ABJT_116.GA1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-158-38|158|994|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-1|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-2|159|448|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-3|159|434|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-4|159|441|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-5|159|539|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-6|159|518|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-7|159|420|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-8|159|539|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-9|159|693|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-10|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-11|159|462|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-12|159|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-13|159|399|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-14|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-15|159|546|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-16|159|525|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-17|159|280|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-18|159|259|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-19|159|371|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-20|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-21|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-22|159|385|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-23|159|469|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-24|159|406|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-25|159|427|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-26|159|343|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-27|159|441|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-28|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-29|159|273|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-30|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-31|159|714|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-32|159|378|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-33|159|448|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-34|159|532|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-35|159|532|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-36|159|504|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-37|159|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-38|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-39|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-1|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-2|159|448|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-3|159|434|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-4|159|441|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-5|159|539|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-6|159|518|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-7|159|420|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-8|159|539|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-9|159|693|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-10|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-11|159|462|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-12|159|490|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 268 - adenocarcinoma|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-13|159|399|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-14|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-15|159|546|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-16|159|525|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-17|159|280|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-18|159|259|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-19|159|371|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-20|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-21|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-22|159|385|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-23|159|469|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-24|159|406|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-25|159|427|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-26|159|343|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-27|159|441|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-28|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-29|159|273|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-30|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-31|159|714|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-32|159|378|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-33|159|448|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-34|159|532|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-35|159|532|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-36|159|504|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-37|159|721|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-38|159|392|Other deterministic changes|Mammary gland|n/a|
11-1-159|N15BnOe-Gy 0.15,ABJT_116.GB1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|39 (39 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-159-39|159|490|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-1|160|427|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-2|160|441|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-3|160|476|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-4|160|525|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-5|160|525|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-6|160|630|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-7|160|637|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-8|160|658|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-9|160|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-10|160|679|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-11|160|693|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-12|160|700|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-13|160|728|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-14|160|728|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-15|160|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-16|160|749|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-17|160|756|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-18|160|770|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-19|160|770|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-20|160|791|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-21|160|791|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-22|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-23|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-24|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-25|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-26|160|805|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-27|160|805|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-28|160|812|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-29|160|812|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-30|160|819|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-31|160|826|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-32|160|847|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-33|160|847|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-34|160|868|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-35|160|875|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-36|160|889|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-37|160|889|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-38|160|924|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-1|160|427|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-2|160|441|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-3|160|476|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-4|160|525|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-5|160|525|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-6|160|630|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-7|160|637|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-8|160|658|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-9|160|672|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-10|160|679|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-11|160|693|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-12|160|700|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-13|160|728|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-14|160|728|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-15|160|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-16|160|749|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-17|160|756|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-18|160|770|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-19|160|770|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-20|160|791|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-21|160|791|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-22|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-23|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-24|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-25|160|798|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-26|160|805|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-27|160|805|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-28|160|812|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-29|160|812|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-30|160|819|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-31|160|826|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-32|160|847|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-33|160|847|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-34|160|868|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-35|160|875|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-36|160|889|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-37|160|889|Other deterministic changes|Mammary gland|n/a|
11-1-160|N15BnOv-Gy 0.15,ABJT_116.GC1NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|38 (38 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-160-38|160|924|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-1|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-2|161|595|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-3|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-4|161|511|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-5|161|665|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-6|161|525|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-7|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-8|161|497|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-9|161|616|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-10|161|637|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-11|161|595|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-12|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-13|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-14|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-15|161|469|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-16|161|455|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-17|161|581|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-18|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-19|161|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-20|161|490|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-21|161|665|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-22|161|714|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-23|161|455|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-24|161|434|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-25|161|497|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-26|161|546|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-27|161|336|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-28|161|616|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-29|161|406|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-30|161|714|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-31|161|483|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-32|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-33|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-34|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-35|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-36|161|210|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-37|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-38|161|448|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-39|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|1| 56|neutrons>10 MeV|0.15|grays|External exposure| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-40|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-1|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-2|161|595|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-3|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-4|161|511|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-5|161|665|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-6|161|525|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-7|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-8|161|497|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-9|161|616|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-10|161|637|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-11|161|595|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-12|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-13|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-14|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-15|161|469|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-16|161|455|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-17|161|581|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-18|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-19|161|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-20|161|490|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-21|161|665|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-22|161|714|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-23|161|455|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-24|161|434|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-25|161|497|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-26|161|546|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-27|161|336|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-28|161|616|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-29|161|406|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-30|161|714|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-31|161|483|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-32|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-33|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-34|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-35|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-36|161|210|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-37|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-38|161|448|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-39|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-40|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-1|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-2|161|595|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-3|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-4|161|511|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-5|161|665|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-6|161|525|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-7|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-8|161|497|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-9|161|616|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-10|161|637|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-11|161|595|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-12|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-13|161|413|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-14|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-15|161|469|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-16|161|455|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-17|161|581|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-18|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-19|161|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  6,MPATH: 268 - adenocarcinoma|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-20|161|490|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-21|161|665|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-22|161|714|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-23|161|455|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-24|161|434|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-25|161|497|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-26|161|546|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-27|161|336|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-28|161|616|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-29|161|406|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-30|161|714|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-31|161|483|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-32|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-33|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-34|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-35|161|308|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-36|161|210|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-37|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-38|161|448|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-39|161|532|Other deterministic changes|Mammary gland|n/a|
11-1-161|N15aOeOv-Gy 0.15,ABJT_116.GD1NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|40 (40 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-161-40|161|357|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-1|162|231|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-2|162|266|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-3|162|301|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-4|162|308|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-5|162|308|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-6|162|308|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-7|162|322|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-8|162|364|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-9|162|378|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-10|162|378|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-11|162|392|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-12|162|413|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-13|162|420|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-14|162|427|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-15|162|434|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-16|162|434|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-17|162|441|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-18|162|448|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-19|162|448|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-20|162|462|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 266 - fibroadenoma|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-21|162|462|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-22|162|462|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-23|162|469|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-24|162|469|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-25|162|469|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-26|162|469|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-27|162|469|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-28|162|490|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-29|162|490|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-30|162|490|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-31|162|497|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-32|162|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 218 - neoplasm|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-33|162|511|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-34|162|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-35|162|588|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-36|162|595|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-37|162|595|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-38|162|623|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-39|162|630|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-40|162|637|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-41|162|686|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 268 - adenocarcinoma|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-42|162|693|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-43|162|700|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-44|162|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-45|162|763|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 218 - neoplasm|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-46|162|826|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-47|162|854|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-48|162|868|Other deterministic changes|Mammary gland|n/a|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-49|162|903|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-162|N15Bn-Gy 0.5,ABJT_116.MA5NIH ABJT_116.MA2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|50 (50 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-162-50|162|91|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-1|163|392|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-2|163|413|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-3|163|441|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-4|163|371|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-5|163|343|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-6|163|441|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-7|163|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-8|163|399|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-9|163|392|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-10|163|441|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-11|163|497|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-12|163|420|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-13|163|378|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-14|163|553|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-15|163|392|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-16|163|273|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-17|163|336|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-18|163|539|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-19|163|196|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-20|163|448|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-1|163|392|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-2|163|413|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-3|163|441|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-4|163|371|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-5|163|343|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-6|163|441|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-7|163|504|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  3,MPATH: 266 - fibroadenoma|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-8|163|399|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-9|163|392|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-10|163|441|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-11|163|497|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-12|163|420|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-13|163|378|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-14|163|553|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-15|163|392|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-16|163|273|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-17|163|336|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-18|163|539|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-19|163|196|Other deterministic changes|Mammary gland|n/a|
11-1-163|N15BnOe-Gy 0.5,ABJT_116.MB2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-163-20|163|448|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-1|164|357|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-2|164|455|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-3|164|490|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-4|164|609|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-5|164|679|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-6|164|686|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-7|164|693|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-8|164|714|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-9|164|728|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-10|164|735|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-11|164|763|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-12|164|763|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-13|164|763|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-14|164|777|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-15|164|777|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-16|164|791|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-17|164|812|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-18|164|812|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-19|164|847|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-1|164|357|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-2|164|455|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-3|164|490|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-4|164|609|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-5|164|679|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-6|164|686|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-7|164|693|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-8|164|714|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-9|164|728|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-10|164|735|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-11|164|763|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-12|164|763|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-13|164|763|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-14|164|777|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-15|164|777|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-16|164|791|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-17|164|812|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-18|164|812|Other deterministic changes|Mammary gland|n/a|
11-1-164|N15BnOv-Gy 0.5,ABJT_116.MC2NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-164-19|164|847|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-1|165|427|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-2|165|560|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-3|165|441|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-4|165|455|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-5|165|434|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-6|165|602|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-7|165|616|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-8|165|364|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-9|165|616|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-10|165|476|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-11|165|413|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-12|165|469|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-13|165|518|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-14|165|581|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-15|165|455|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-16|165|553|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-17|165|448|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-18|165|441|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-19|165|504|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|1| 56|neutrons>10 MeV|0.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-20|165|623|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-1|165|427|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-2|165|560|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-3|165|441|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-4|165|455|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-5|165|434|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-6|165|602|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-7|165|616|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-8|165|364|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-9|165|616|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-10|165|476|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-11|165|413|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-12|165|469|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-13|165|518|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-14|165|581|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-15|165|455|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-16|165|553|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-17|165|448|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-18|165|441|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-19|165|504|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-20|165|623|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-1|165|427|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-2|165|560|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-3|165|441|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-4|165|455|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-5|165|434|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-6|165|602|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-7|165|616|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-8|165|364|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-9|165|616|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-10|165|476|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-11|165|413|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-12|165|469|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-13|165|518|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-14|165|581|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-15|165|455|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-16|165|553|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-17|165|448|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-18|165|441|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-19|165|504|Other deterministic changes|Mammary gland|n/a|
11-1-165|N15aOeOv-Gy 0.5,ABJT_116.MD2NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-165-20|165|623|Other deterministic changes|Mammary gland|n/a|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-1|166|357|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-2|166|392|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-3|166|532|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-4|166|546|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-5|166|553|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-6|166|553|Other deterministic changes|Mammary gland|n/a|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-7|166|560|Other deterministic changes|Mammary gland|n/a|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-8|166|595|Other deterministic changes|Mammary gland|n/a|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-9|166|623|Other deterministic changes|Mammary gland|n/a|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-10|166|623|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  1,MPATH: 218 - neoplasm|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-11|166|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-12|166|630|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  3,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-13|166|658|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  7,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-14|166|665|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  2,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-15|166|686|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-16|166|714|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  2,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-17|166|735|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-166|N15Bn-Gy 1.5,ABJT_116.PA3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|18 (18 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-166-18|166|742|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-1|167|518|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-2|167|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-3|167|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-4|167|364|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-5|167|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-6|167|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-7|167|567|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-8|167|539|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-9|167|357|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-10|167|441|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-11|167|623|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-12|167|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-13|167|343|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-14|167|441|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-15|167|511|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-16|167|343|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-17|167|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-18|167|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-19|167|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-20|167|518|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-1|167|518|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-2|167|518|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-3|167|490|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-4|167|364|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-5|167|567|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-6|167|567|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 268 - adenocarcinoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-7|167|567|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-8|167|539|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-9|167|357|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-10|167|441|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-11|167|623|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-12|167|546|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-13|167|343|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-14|167|441|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-15|167|511|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-16|167|343|Other deterministic changes|Mammary gland|n/a|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-17|167|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-18|167|644|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-19|167|581|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  0,MPATH: 266 - fibroadenoma|
11-1-167|N15BnOe-Gy 1.5,ABJT_116.PB3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-167-20|167|518|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-1|168|252|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-2|168|469|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-3|168|490|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-4|168|532|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-5|168|574|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-6|168|595|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-7|168|602|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-8|168|630|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-9|168|651|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-10|168|700|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-11|168|700|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-12|168|700|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-13|168|714|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-14|168|735|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-15|168|749|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-16|168|777|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-17|168|777|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-18|168|875|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-19|168|168|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-1|168|252|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-2|168|469|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-3|168|490|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-4|168|532|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-5|168|574|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-6|168|595|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-7|168|602|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-8|168|630|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-9|168|651|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-10|168|700|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-11|168|700|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-12|168|700|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-13|168|714|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-14|168|735|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-15|168|749|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-16|168|777|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-17|168|777|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-18|168|875|Other deterministic changes|Mammary gland|n/a|
11-1-168|N15BnOv-Gy 1.5,ABJT_116.PC3NIH|2| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|19 (19 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-168-19|168|168|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-1|169|553|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-2|169|574|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-3|169|532|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-4|169|532|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-5|169|567|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-6|169|588|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-7|169|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-8|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-9|169|602|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-10|169|567|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-11|169|546|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-12|169|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-13|169|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-14|169|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-15|169|504|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-16|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-17|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-18|169|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-19|169|525|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|1| 56|neutrons>10 MeV|1.5|grays|External exposure| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-20|169|560|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-1|169|553|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-2|169|574|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-3|169|532|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-4|169|532|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-5|169|567|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-6|169|588|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-7|169|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-8|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-9|169|602|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-10|169|567|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-11|169|546|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-12|169|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-13|169|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-14|169|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-15|169|504|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-16|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-17|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-18|169|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-19|169|525|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|2| 49|estrogen|2|milligrams|Implantation| n/a|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-20|169|560|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-1|169|553|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-2|169|574|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-3|169|532|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-4|169|532|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-5|169|567|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-6|169|588|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-7|169|497|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  8,MPATH: 268 - adenocarcinoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-8|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-9|169|602|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-10|169|567|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-11|169|546|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-12|169|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  5,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-13|169|560|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  0,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-14|169|483|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 6 Size  4,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-15|169|504|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-16|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-17|169|497|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-18|169|476|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland| Nipple 2 Size  4,MPATH: 266 - fibroadenoma|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-19|169|525|Other deterministic changes|Mammary gland|n/a|
11-1-169|N15aOeOv-Gy 1.5,ABJT_116.PD3NIH|3| 40|ovarectomy||unit code not relevant|not applicable or not supplied| ovarectomy|20 (20 in ERA)|Rat|Rat Brown Norway (BN/BRIJ)|Female|Young Adult|visible/palpable tumors|11-1-169-20|169|560|Other deterministic changes|Mammary gland|n/a|
		
